All relevant data are within the paper and its Supporting Information files.

Introduction {#sec006}
============

The cumulative incidence of patients seeking healthcare post-whiplash from a road traffic accident has increased over the last 30 years to an annual incidence of between 3 and 6/1000 inhabitants in North America and Western Europe \[[@pone.0194235.ref001]\]. Following injury, individuals experience a range of clinical manifestations, described as Whiplash Associated Disorder (WAD), including neck pain, fatigue, nausea, low self-reported physical and mental health, cognitive impairments and pain in multiple sites \[[@pone.0194235.ref002]\]. The severity of presentation in WAD is categorised according to the Quebec Task Force Classification (QTF) where the presence of clinical signs and symptoms relate to the severity of the disorder \[[@pone.0194235.ref003]\].

Whilst research has identified risk factors for poor prognosis \[[@pone.0194235.ref004], [@pone.0194235.ref005]\], and enhanced understanding of neurophysiological changes \[[@pone.0194235.ref006]\], it is not known why disability and pain persist beyond normal tissue healing times. With 40--60% patients progressing to experience chronic whiplash associated disorder (CWAD), estimated costs of \~\$4 billion (USA) and \~€10 billion (Europe) associated with management and time off work \[[@pone.0194235.ref007], [@pone.0194235.ref008]\], further research is needed to fully understand anatomical dysfunction in WAD and provide new directions for clinical practice and research. This includes the effects on anatomically related body regions, such as the thoracic spine. Potential ongoing dysfunction in the thoracic region may partially explain why there is inconclusive evidence for the effectiveness of physiotherapy management for WAD II, where interventions target a primary complaint of neck pain \[[@pone.0194235.ref009], [@pone.0194235.ref010]\].

Although current research into WAD has focused on the primary complaint of neck pain \[[@pone.0194235.ref011]\], symptoms may also include stiffness \[[@pone.0194235.ref012], [@pone.0194235.ref013]\] and pain in other regions including the jaw, head, upper and lower limbs, chest, abdomen and groin \[[@pone.0194235.ref014]\]. Moreover, data from a large cohort study (n = 6481) reported that 66% of individuals complained of thoracic mid-spine pain post whiplash injury, with 23% still experiencing symptoms one year later \[[@pone.0194235.ref014]\]. This is not surprising given the mechanism of a whiplash injury which involves forceful stretch loading to the upper back muscles; muscles which span both the neck and thoracic spine \[[@pone.0194235.ref015]\]. Recent evidence supports the presence of pathology in the mid/lower fibres of the trapezius muscle where they insert onto bone (myofascial-entheseal dysfunction) \[[@pone.0194235.ref016]\], which may partly account for the high prevalence of thoracic pain reported in both acute (65.5%) \[[@pone.0194235.ref014]\] and \>80% in chronic WAD \[[@pone.0194235.ref017]\]. Furthermore, a number of abnormalities have been documented for the trapezius muscle in people with chronic WAD including histological changes as well as changes in muscle behaviour \[[@pone.0194235.ref018], [@pone.0194235.ref019]\].

With reduced cervical mobility being characteristic of chronic WAD and evidence that the thoracic spine contributes up to 33% and 21% of the movement occurring during neck flexion and rotation respectively \[[@pone.0194235.ref020]\] perhaps thoracic mobility is impaired following a whiplash injury; however at this time relatively little is known about the impact of WAD on this spinal region \[[@pone.0194235.ref021]\]. Research is now needed to examine the impact of injury on the thoracic spine in WAD.

Nevertheless, a systematic review of the current evidence has never been conducted to examine the scope and nature of dysfunction/impairment in the thoracic spine region following whiplash injury and in WAD. Knowledge of such dysfunction may be used to inform clinical practice and examination of patients with WAD, but also future clinical trials of novel interventions targeting thoracic impairments in WAD.

Objectives {#sec007}
----------

The primary objective is to evaluate the scope and nature of dysfunction in the thoracic spine region in patients with WAD. A secondary objective is to explore the scope and nature of such changes based on severity using the Quebec Task Force classification (I-III) and stage post injury (acute/sub-acute less than 3 months or chronic 3+ months). Thirdly, we wish to make evidence based recommendations for clinical practice and future research.

Methods/Design {#sec008}
==============

Protocol and registration {#sec009}
-------------------------

A systematic review of all forms of observational study was conducted according to a pre-defined protocol \[[@pone.0194235.ref022]\], in line with the Centre of Research and Dissemination Guidelines \[[@pone.0194235.ref023]\], Meta-analyses of Observational Studies in Epidemiology (MOOSE) \[[@pone.0194235.ref024]\] and is reported in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (*PRISMA*) \[[@pone.0194235.ref025]\], [S1 Table](#pone.0194235.s001){ref-type="supplementary-material"}. PROSPERO (Registration number: CRD42015026983).

Eligibility criteria {#sec010}
--------------------

Eligibility criteria informed using SPIDER \[[@pone.0194235.ref026]\], included that the sample (S) comprised patients aged \>19 years; the phenomenon of interest (PI) was a WAD following motor vehicle or sporting injury; investigated using an observational study design (cohort, case control, single case study) (D) with evaluation of patient reported or performance based measure(s) of thoracic dysfunction of one or more of the following: muscle with an insertion to the thoracic cage, bone or joint of the thoracic cage, neural tissue related to the thorax (E).

Exclusion criteria included: studies investigating upper trapezius, studies investigating a central pain mechanism or neurophysiology of pain where no testing took place in the thoracic region, simulation or modelling studies, fractures (WAD IV), visceral injury or fibromyalgia.

Information sources {#sec011}
-------------------

The search employed sensitive topic-based strategies designed for each database from inception to 1/6/16. No language or geographical restrictions were included. Databases included, CINAHL, EMBASE, MEDLINE, ZETOC, Index to Chiropractic Literature ChiroAccess and Google Scholar. Selected Internet sites and Indexes including, Turning Research into Practice, PubMed, National Research Register and Cochrane Back Review Group were also searched. Hand searching of key journals included Spine and the European Spine Journal. Grey literature included British National Bibliography for Report Literature, Dissertation Abstracts, Index to Scientific and Technical Proceedings, National Technical Information Service and the System for Information on Grey Literature.

Search strategy {#sec012}
---------------

The search strategy included terms related to whiplash associated disorder and patient reported or performance based measures of thoracic dysfunction. Terms and keywords derived from the scoping search and experts \[subject specific (NRH,AR) and methodological (NRH,AR)\] included: 'whiplash', 'whiplash associated disorder', 'WAD', 'whiplash injury', 'motor vehicle accident OR collision', 'road traffic accident', 'cervical strain' and 'thoracic spine', 'dorsal spine', 'mid-spine', 'thoracic injuries', limiting to adults \>19 years and diagnosis to achieve the best balance of sensitivity and specificity. An example a search from Medline is included [S2 Table](#pone.0194235.s002){ref-type="supplementary-material"}. Terms were adapted to reflect spelling differences and \[[@pone.0194235.ref014]\] unique searching features of individual databases. Reference lists of included papers were also searched.

Study selection {#sec013}
---------------

Two reviewers (NRH, RS) independently searched information sources and assessed identified studies for inclusion, facilitated by grading each eligibility criterion as eligible/not eligible/might be eligible \[[@pone.0194235.ref027]\]. Full texts were reviewed and included when both reviewers agreed \[[@pone.0194235.ref023]\]. A third reviewer (IT) mediated in the event of disagreement \[[@pone.0194235.ref028]\].

Data collection process and items {#sec014}
---------------------------------

Using a standardised form, the two reviewers extracted data independently \[[@pone.0194235.ref023]\]. A further reviewer (IT) independently examined data for accuracy and clarity. Authors were contacted for additional information or data where required.

Data items {#sec015}
----------

Data were extracted from each study, including: study design, sample characteristics including age, gender, severity of WAD using the QTF Classification if reported, time point post injury and patient reported or performance based measures of thoracic dysfunction.

Risk of bias in individual studies {#sec016}
----------------------------------

Risk of bias for each included study was independently assessed by the same initial reviewers. The third reviewer mediated in situations of disagreement. All tools and processes were piloted prior to use. Risk of bias was only assessed for cohort and case-control studies using the Newcastle-Ottawa Scale \[[@pone.0194235.ref029]\]; that includes eight items that are rated and categorised into three groups, namely selection, comparability and outcome.

Summary measures {#sec017}
----------------

Summary measures of patient reported or performance based measures of thoracic dysfunction are presented in the form of prevalence data and confidence intervals where provided, for thoracic pain, chest pain, thoracic outlet syndrome (TOS), myofascial pain and trigger points, dysfunction involving the brachial plexus, thoracic spine posture or mobility. Results are presented where possible, according to severity (QTF) and stage of WAD i.e. acute/sub-acute (\< 3 months) or chronic (\> 3 months).

Synthesis of results {#sec018}
--------------------

In accordance with the protocol \[[@pone.0194235.ref022]\] meta-analyses would be performed where a sufficient number of studies share all of the stated characteristics; design, measure of dysfunction, severity based on QTF and stage post whiplash injury.

Quality of evidence across studies {#sec019}
----------------------------------

Quality of evidence, including risk of bias across studies was evaluated using GRADE \[[@pone.0194235.ref030]\] for individual outcomes of interest. By their very nature, observational studies are considered 'low quality' although could be *upgraded* where a large dose response was evident, or the effects could not be accounted for by bias \[[@pone.0194235.ref030]\]. Likewise, findings could be downgraded to '*very low*' where concerns were identified from the body of studies relating to precision, consistency, directness, precision or potentially other additional domains relating to strength of association e.g. magnitude of effect \[[@pone.0194235.ref030]\].

Results {#sec020}
=======

Study selection {#sec021}
---------------

A total of 38 studies met the eligibility criteria, including 19 cohort studies, 16 case control studies and 3 single case studies/reports. The process of selection is detailed in [Fig 1](#pone.0194235.g001){ref-type="fig"}, with the list of excluded studies and reasons provided [S3 Table](#pone.0194235.s003){ref-type="supplementary-material"}.

![Flow chart of search and study selection.](pone.0194235.g001){#pone.0194235.g001}

Study characteristics {#sec022}
---------------------

Study characteristics are detailed in [Table 1](#pone.0194235.t001){ref-type="table"}. A range of measures of thoracic dysfunction were identified, including thoracic pain, chest pain, involvement of the brachial plexus, thoracic outlet syndrome, changes in muscle activation *etc*. An overview of the types of dysfunction is provided in [Table 2](#pone.0194235.t002){ref-type="table"} and, where possible, is presented according to severity and stage following injury.

10.1371/journal.pone.0194235.t001

###### Study characteristics.

![](pone.0194235.t001){#pone.0194235.t001g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author & Date                                                                Design                                                                 WAD patients                                                           Age\                                                         Sample                                                     Assessment                                                                                  Findings
                                                                                                                                                                                                                             Gender                                                                                                                                                                                                              
  ---------------------------------------------------------------------------- ---------------------------------------------------------------------- ---------------------------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------------------- ------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------
  Alexandre 2005\[[@pone.0194235.ref031]\]                                     Cohort                                                                 '**Mild car accidents**', mainly rear shunts\                          Mean (range) age 36.5 (19--57) years\                        N = 24                                                     • Clinical examination\                                                                     **Thoracic outlet syndrome due to brachial plexus entrapment**\
                                                                                                                                                      **Chronic:** 2--48 months post injury                                  • Female n = 20\                                                                                                        • X-ray of the cervical spine and 'possibly MRI or CT scan'\                                • Right side n = 13\
                                                                                                                                                                                                                             • Male n = 4                                                                                                            • Electrodiagnostic testing                                                                 • Left side n = 9\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Bilaterally n = 9

  Berglund2001\[[@pone.0194235.ref032]\]                                       Case control although stated cohort design applied?                    **Minor WAD** (including n = 1 severe, n = 4 moderate)\                No data                                                      N = 4124\                                                  Postal questionnaire                                                                        **Thoracic pain prevalence post rear end collision** (%, 95% CI, and number)\
                                                                                                                                                      **Chronic:** 7 years +                                                                                                              • Exposed with WAD = 242\                                                                                                                              • **Injury with WAD: 15.3% (10.4--21.5), 27/176**\
                                                                                                                                                                                                                                                                                          • Exposed without WAD = 204\                                                                                                                           • Injury without WAD: 6.7% (3.1--12.3), 9/135\
                                                                                                                                                                                                                                                                                          • Unexposed comparison = 3688                                                                                                                          • No injury: 4.4% (3.3--5.8), 52/1173

  Bismil 2012\[[@pone.0194235.ref016]\]                                        Cohort                                                                 **Chronic WAD II** (\>6 mths)                                          For sub group: mean age 42 years\                            N = 1025 with sub group n = 25                             Clinical examination                                                                        **Myofascial-entheseal dysfunction**\
                                                                                                                                                                                                                             • Female 56%\                                                                                                                                                                                                       • Bilateral 60%; unilateral 40%\
                                                                                                                                                                                                                             • Male 44%                                                                                                                                                                                                          • Middle trapezius 56%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Lower trapezius 12%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Enthesopathy** (myofascial pain and trigger points) n = 25\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • middle and lower parts of trapezius\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • scapular attachment\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 48%

  Bock2005\[[@pone.0194235.ref033]\]                                           Cohort (reliability study)                                             **Chronic WAD** (\>3 mths)\                                            Mean, range (SD) age 40.9, 16--72 (14.8) years\              N = 31, (9 excluded)                                       Clinical examination\                                                                       **Thoracic allodynia** 71% of sample\
                                                                                                                                                      • 11/31 WADI\                                                          • Females n = 17\                                                                                                                                                                                                   • Lower thoracic segments are most commonly involved
                                                                                                                                                      • 20/31 WADII                                                          • Males n = 5                                                                                                                                                                                                       

  Bodack 1998\[[@pone.0194235.ref034]\]                                        Case report                                                            **Acute WAD(?III)**                                                    19 years\                                                    N = 1                                                      • Clinical examination\                                                                     **Upper back pain**\
                                                                                                                                                                                                                             Female                                                                                                                  • Electrodiagnostic studies                                                                 • Weak mid and lower trapezius\

  Bortsov2014\[[@pone.0194235.ref011]\]                                        Cohort\                                                                **Mild** (99% AIS1)\                                                   Age tertiles at baseline\                                    N = 948 completed baseline evaluations\                    Evaluation via telephone interview or a web-based questionnaire.                            **Thoracic and chest pain**\
                                                                               8 Emergency Depts                                                      **WADI & II** (**acute, sub-acute, chronic**)                          • 18--26 years n = 315\                                      • -859/948 (91%) fu at 6 weeks,\                                                                                                                       • **47% prevalence of upper back pain** at 6 weeks (18% being widespread. 29% localised)\
                                                                                                                                                                                                                             • 27--41 years n = 319\                                      • -839/948 (89%) fu 6 months\                                                                                                                          • **19% prevalence of chest pain** at 6 weeks (9% being widespread, 10% localised)\
                                                                                                                                                                                                                             • 42--65 years n = 314                                       • -861/948 (91%) fu at one year                                                                                                                        *No data available for other time points*, *authors contacted*

  Capistrant1976\[[@pone.0194235.ref035]\]                                     Cohort                                                                 **WAD with TOS**\                                                      Mean (range) age 40 (21--59) years\                          N = 35\                                                    • Cervical x-ray\                                                                           **Thoracic outlet syndrome**\
                                                                                                                                                      • **Acute** n = 14**Chronic** n = 16                                   • Female n = 17\                                             TOS group n = 30                                           • Clinical examination\                                                                     • Unilateral symptoms n = 25\
                                                                                                                                                                                                                             • Male n = 13                                                                                                           • Electrodiagnostic testing                                                                 • Bilateral symptoms n = 5

  Capistrant1986\[[@pone.0194235.ref036]\]                                     Cohort                                                                 **WAD** (including cervical strains)                                   Mean age 30 years\                                           N = 111                                                    • Clinical examination\                                                                     **Thoracic outlet syndrome**\
                                                                                                                                                                                                                             • Females n = 32\                                                                                                       • Electrodiagnostic studies                                                                 • TOS n = 40/111, 36%
                                                                                                                                                                                                                             Males n = 8                                                                                                                                                                                                         

  Castaldo2014\[[@pone.0194235.ref037]\]                                       Case control                                                           **Chronic WADII & III**\                                               Mean (SD) age41.6 (1.72)\                                    N = 49                                                     Clinical examination                                                                        **SCM Myofascial trigger points**\
                                                                                                                                                      Control (Mechanical neck pain)                                         • Females n = 28\                                                                                                                                                                                                   • Latent MTP left 13, right 15\
                                                                                                                                                                                                                             • Males n = 21                                                                                                                                                                                                      • Active MTP left 21, right 22\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **MNP group:**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Latent MTP left 6, right 9\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Active MTP left 13, right 13

  Chien 2009\                                                                  Case control                                                           **Chronic WADII** (3mths-3 years)                                      **WAD** Mean (SD) age 35.3 (10.7) years\                     WAD N = 31\                                                Clinical examination                                                                        **BPTT (from 180-degree extension elbow)**\
  \[[@pone.0194235.ref038]\]                                                                                                                                                                                                 Females n = 25                                                                                                                                                                                                      • WAD -22.3 (27.4) degrees VAS 2.4 (2.3)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control -11 (5.9) VAS 0.7 (1.1)

  **Control** Mean (SD) age 31.4 (8.9) years\                                  Control N = 31                                                                                                                                                                                                                                                                                                                                                    
  Females n = 25                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Cornips2014 \[[@pone.0194235.ref039]\]                                       Case series of surgical cases for TDH                                  **Chronic WAD**                                                        Range age 26--58\                                            N = 10\                                                    Clinical examination and imaging (from 326 discectomies for ≥ 1 thoracic disc herniation)   **Thoracic pain (local) with thoracic disc herniation**\
                                                                                                                                                                                                                             • Females n = 7\                                             (N = 4 had 'typical whiplash based on MOI & complaints)                                                                                                N = 10, ranging from significant axial pain to paretic-paralytic (significant motor weakness)\
                                                                                                                                                                                                                             • Males n = 3                                                                                                                                                                                                       • Significant axial and thoracic radicular pain n = 1\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Significant axial and lower leg pain with or without thoracic radicular pain n = 3

  Ettlin2008\[[@pone.0194235.ref040]\]                                         Case control                                                           **Chronic WAD** (with or without neurological deficit were included)   **WAD**\                                                     WAD N = 47\                                                Clinical examination                                                                        **Myofascial trigger points scaleneus medius and SCM)**\
                                                                                                                                                                                                                             Mean (SD) age 38.57 (10.18) years\                                                                                                                                                                                  Prevalence (%)\
                                                                                                                                                                                                                             Females n = 35 (74.5%)\                                                                                                                                                                                             **WAD**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Scaleneus medius 30 (63.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • SCM 24 (51.1)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Control**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Scaleneus medius 3 (12.5)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • SCM 3 (12.5)

  **Control**\                                                                 Control N = 24                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) age 37.42 (11.34) years\                                                                                                                                                                                                                                                                                                                                                                                                             
  Females n = 1 (45.8%)                                                                                                                                                                                                                                                                                                                                                                                                                          

  Fernandez-Perez2012 \[[@pone.0194235.ref041]\]                               Case control                                                           **Sub-acute WADII** *(states acute in text)*Within 1 month             **WAD**\                                                     WAD N = 20                                                 Clinical examination                                                                        **Myofascial trigger points (scaleneus medius and SCM)**\
                                                                                                                                                                                                                             Mean (SD) age 28.7 (12.4) years                                                                                                                                                                                     Number of participants with MTP\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **WAD**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Scalene Active R 6, L4, Latent R 9, L10, No R 5, L6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • SCM Active R1, L6, Latent R12, L9, No R7, L5\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Control**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Scalene Active R0, L0, Latent R2, L4, No R 18, L16\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • SCM Active R0, L0, Latent R4, L5, No R 6, L15

  **Control**\                                                                 Control N = 20                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) age 29.1 (12.2) years                                                                                                                                                                                                                                                                                                                                                                                                                

  Ferrari2010 \[[@pone.0194235.ref042]\]                                       Cohort                                                                 **WADI & II (acute, sub-acute)**Presented at 7 days, FU at 3 months    Mean, range (SD) age 37.5, 18--71 (13) years\                N = 69                                                     Clinical examination                                                                        **Brachial plexus provocation test (Pain and elbow ROM)**\
                                                                                                                                                                                                                             • Female n = 37\                                                                                                                                                                                                    **3 months:**\
                                                                                                                                                                                                                             • Male n = 32                                                                                                                                                                                                       • VAS: mean (SD)2.2 (1.2)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Elbow extension: 41.5 (23) degrees\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Expectation predicted elbow angle and VAS on BPPT at 3 months**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Significantly smaller angle when expected to 'get better slowly' or 'get better soon' vs the other 2 categories\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 VAS for 'get better soon' 1 point less than other 3 groups

  Hartling2002\[[@pone.0194235.ref043]\]                                       Cohort                                                                 **WADI-III**\<2 weeks and 6 mths                                       No details                                                   N = 380                                                    Clinical examination                                                                        **Upper back pain**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 \<2 weeks: 74.6% adjusted OR 2.91 (1.65,5.12)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 ***Symptoms intensity OR (95%CI)***\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • *Mild 3*.*09 (1*.*50*, *6*.*38)*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • *Moderate 4*.*17 (2*.*08*, *8*.*36)*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • *Severe 15*.*63 (6*.*07*, *41*.*51)*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 ***Symptoms frequency OR (95%CI)***\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • *Mild 3*.*47 (1*.*25*, *9*.*66)*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • *Moderate 5*.*36 (2*.*84*, *10*.*17)*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • *Severe 5*.*30 (2*.*53*, *11*.*18)*

  Helgadottir2011a\[[@pone.0194235.ref044]\](sub group of Helgadottir, 2011)   Case control                                                           **Chronic WADII** (\>6 mths)                                           **WADII**\                                                   WAD N = 23\                                                Clinical examination                                                                        In WAD group: No difference was found in the **mid thoracic curve** (*p* = .99)
                                                                                                                                                                                                                             Mean (SD) age 33.37 (9.58) years\                                                                                                                                                                                   
                                                                                                                                                                                                                             NDI 38 (18.74)\                                                                                                                                                                                                     
                                                                                                                                                                                                                             • Female n = 20\                                                                                                                                                                                                    
                                                                                                                                                                                                                             Male n = 3                                                                                                                                                                                                          

  **Control**\                                                                 Control N = 20                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) 29.70 (7.75) years\                                                                                                                                                                                                                                                                                                                                                                                                                  
  • Female n = 17\                                                                                                                                                                                                                                                                                                                                                                                                                               
  • Male n = 3                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Helgadottir2011b \[[@pone.0194235.ref045]\]                                  Case control                                                           **Chronic WADII** (\>6 mths)                                           **WADII**\                                                   WAD N = 27                                                 Electromyography                                                                            **Muscle activation and duration** (middle trapezius, lower trapezius and serratus anterior)\
                                                                                                                                                                                                                             Mean (SD) age\                                                                                                                                                                                                      • **Delayed onset of serratus anterior muscle** activation in the WAD group (P \< .01)\
                                                                                                                                                                                                                             33 (10) years\                                                                                                                                                                                                      • **Reduced duration of muscle activity** in the WAD group (P \< .01)\
                                                                                                                                                                                                                             VAS 6(2)\                                                                                                                                                                                                           • No change in in middle and lower trapezius
                                                                                                                                                                                                                             NDI 38 (18)\                                                                                                                                                                                                        
                                                                                                                                                                                                                             • Female n = 24\                                                                                                                                                                                                    
                                                                                                                                                                                                                             Male n = 3                                                                                                                                                                                                          

  **Control**\                                                                 Control N = 23                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD)\                                                                                                                                                                                                                                                                                                                                                                                                                                     
  30 (8) years\                                                                                                                                                                                                                                                                                                                                                                                                                                  
  • Female n = 18\                                                                                                                                                                                                                                                                                                                                                                                                                               
  • Male n = 5                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Hincapie2010 \[[@pone.0194235.ref014]\]                                      Cohort                                                                 **WAD**\<30 days post traffic injury                                   Mean (SD) age37.2 (15.2) years\                              N = 6481                                                   Clinical examination                                                                        **Mid back pain**\
                                                                                                                                                                                                                             • Female 60.2%\                                                                                                                                                                                                     • Prevalence % (95%CI) 65.5 (64.4--66.7)\
                                                                                                                                                                                                                             • Male 39.8%                                                                                                                                                                                                        • Localised % (95%CI) 0.06 (0.00--0.12)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Posterior shoulder (includes upper thoracic)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Prevalence % (95%CI) 75.3 (74.3--76.4)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Chest pain**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Prevalence, % (95%CI) 18.9 (17.9--19.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Localised % (95%CI) 0.05 (0.00--0.10)

  Holm2007\[[@pone.0194235.ref017]\]                                           Cohort                                                                 **WAD** Approx. 10 days to 6 months                                    Age n (%)≥40 n = 21 (21)\                                    N = 56                                                     Clinical examination                                                                        **Chest pain prevalence, n (%)**\
                                                                                                                                                                                                                             • 30--39 n = 18 (22)\                                                                                                                                                                                               • Baseline -\
                                                                                                                                                                                                                             • 18--29 n = 17 (20)\                                                                                                                                                                                               • 6-weeks 2(6)\
                                                                                                                                                                                                                             • Females = 38 (24%)                                                                                                                                                                                                • 4-months 1(4)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 8-months 2(12)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 12-months 5(22)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Thoracic pain prevalence, n (%)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Baseline 29 (52)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 6-weeks 28 (80)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 4-months 24 (86)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 8-months 16 (94)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 12-months 20 (87)

  Ide2001 \[[@pone.0194235.ref046]\]                                           Cohort                                                                 **WAD** 1week to 6 months                                              Mean, range age\                                             N = 119                                                    • Cervical radiographs\                                                                     **Non-brachial plexus irritation n = 74**\
                                                                                                                                                                                                                             • Males = 36.1,\                                                                                                        • Clinical examination                                                                      **Brachial plexus irritation n = 45**
                                                                                                                                                                                                                             • Females = 35.7\                                                                                                                                                                                                   
                                                                                                                                                                                                                             • 14--61 years                                                                                                                                                                                                      

  Johansson2015\[[@pone.0194235.ref002]\]                                      Cohort from a large population based study                             **WAD**                                                                Median age35.7 (25.3--47.2) years\                           N = 3711 from 8634 eligible cases                          Clinical examination                                                                        **Mid back pain present in 3711 individuals (43%)**\
                                                                                                                                                                                                                             Females = 2484 (66.9%)                                                                                                                                                                                              • Incidence 236/100,000\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Baseline pain rating 6 (5--8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • 23% not recovered at one year

  Kai2001\[[@pone.0194235.ref047]\]                                            Cohort                                                                 **Cervical strain** post cervical trauma                               No data reported                                             N = 110                                                    • Clinical examination\                                                                     Cervical strain n = 29 (no positive tests)\
                                                                                                                                                                                                                                                                                                                                                     • MRI                                                                                       • ?Neurogenic TOS n = 25 (one positive test)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Neurogenic TOS n = 39 (2 or 3 positive tests)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Neurogenic TOS with associated cervical disc disease (n = 17)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Pain (scapular)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Cervical strain 31%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Probable Neurogenic TOS 30%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Neurogenic TOS 46%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Neurogenic TOS with associated cervical disc disease 35%

  Kall 2008\[[@pone.0194235.ref048]\]                                          Longitudinal study using data from previous RCT (use baseline data)\   **WADI-II (sub-acute)** (96% MVAs, 4% falls)                           Mean (range)age 31 (18--61) years\                           N = 47                                                     Clinical examination                                                                        Women with sub-acute WAD C7-T1 flexion hypomobility\
                                                                               Cohort study applied                                                                                                                          • Female n = 30 (64%)\                                                                                                                                                                                              *No baseline data available*, *authors contacted*
                                                                                                                                                                                                                             • Male n = 17 (36%)\                                                                                                                                                                                                

  Klein2001 \[[@pone.0194235.ref049]\]                                         Case control                                                           **Chronic WADI-III** (mainly II)\>3 months                             **WAD**\                                                     WAD N = 46                                                 • Clinical examination\                                                                     **SCM activation**\
                                                                                                                                                                                                                             Mean (SD) 36.4 (10.1) years\                                                                                            • Electromyography                                                                          • No earlier activation during cervical rotation in CWAD\
                                                                                                                                                                                                                             • Female 67%\                                                                                                                                                                                                       (Cervical ROM WAD 84.8 (31)-degrees compared with 137.2 (18.5)-degrees in control)
                                                                                                                                                                                                                             • Male 33%\                                                                                                                                                                                                         
                                                                                                                                                                                                                             **Control**                                                                                                                                                                                                         

  \                                                                            Control N = 48                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) 28.8 (6.7) years\                                                                                                                                                                                                                                                                                                                                                                                                                    
  • Female 58%\                                                                                                                                                                                                                                                                                                                                                                                                                                  
  • Male 42%                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Koelbeck 1999\                                                               Case control                                                           **Chronic WADII**                                                      **WADII**\                                                   WAD N = 11\                                                Clinical examination                                                                        **Infraspinatus region (WAD n = 8)**\
  \[[@pone.0194235.ref050]\]                                                                                                                                                                                                 Mean (range) 42 (28--69) years\                              Control N = 11                                                                                                                                         **Pressure pain threshold (kPa)** Mean (SD)\
                                                                                                                                                                                                                             Female n = 7\                                                                                                                                                                                                       • WAD 152.2 (84.9)\
                                                                                                                                                                                                                             Male n = 4\                                                                                                                                                                                                         • Control 492.8 (18.8)\
                                                                                                                                                                                                                             **Control**\                                                                                                                                                                                                        **Pin prick thresholds** Mean (SD)\
                                                                                                                                                                                                                             Mean (range) 39 (26--50) years\                                                                                                                                                                                     • WAD 11.5 (2.5)\
                                                                                                                                                                                                                             Female n = 7\                                                                                                                                                                                                       • Control 12.4 (1.1)\
                                                                                                                                                                                                                             Male n = 4\                                                                                                                                                                                                         **VAS score (cm)** Mean (SD)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD 5.2 (0.9)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control 5.3 (0.4)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **VAS area (cm sq)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD 4138.1 (1707.2)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control 780.5 (366.3)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **VAS peak (cm)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD 8.7 (1.5)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control 5.2 (1.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **VAS onset (s)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD 22.7 (6.5)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control 35.5 (5)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **VAS duration (s)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD 719.5 (244.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control 317.7 (115.4)

  Magnusson 1994 \[[@pone.0194235.ref051]\]                                    Cohort                                                                 **Chronic WADI-III** (\>6 mths)                                        • Mean (range) age33 (17--52) yearsFemales n = 25 (65.8%)\   N = 38                                                     • Cervical radiographs\                                                                     **Thoracic outlet syndrome** n = 12 (31.6%)\
                                                                                                                                                                                                                             • Males n = 13 (34.2%)                                                                                                  • Clinical examination                                                                      • Unilateral n = 9 (23.7%)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Bilateral n = 3 (7.9%)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 (N = 4 had symptoms, but not reproducible on palpation)

  McLean, 2014 \[[@pone.0194235.ref052]\]                                      Cohort                                                                 **WADI & II**\                                                         Median (range) age36 (18--65) years\                         Acute N = 948\                                             Participant interview\                                                                      **Pain (moderate or severe NRS 4)6 weeks**\
                                                                                                                                                      Data for **acute** (\<24 hours injury) and **sub-acute**(6 weeks)      Females 60.7%\                                               Chronic n = 711 (non-litigant group) 6 weeks: N = 859                                                                                                  • Upper back 21% (18--24%)\
                                                                                                                                                                                                                             (Females 62.6% 6 weeks?sub-acute)                                                                                                                                                                                   • Shoulder (including posterior upper thoracic) 23% (20--26%)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Chest 8% (6--10%)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 *No data available for other time points*, *authors contacted*

  Myran2011\[[@pone.0194235.ref053]\]                                          Cohort                                                                 **Chronic WAD**                                                        Age Mean across subgroups 40.8--56.0)\                       N = 46,895                                                 Questionnaire                                                                               **Chest/abdomen**\
                                                                                                                                                                                                                             Female 44.3--67.1%                                                                                                                                                                                                  [**Men**]{.ul} Total 972\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • N = (%) 68 (7.0)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • OR (95%CI) 3.6 (2.4, 5.2)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 [**Women**]{.ul} Total 1543\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • N = (%) 107 (6.9)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • OR (95%CI) 7.1 (4.9, 10.4)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 [**Upper back**]{.ul}\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Men** Total 1421\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • N = (%) 125 (8.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • OR (95%CI) 5.0 (3.7, 6.7)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Women** Total 3361\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • N = (%) 235 (7.0)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • OR (95%CI) 5.9 (4.4, 7.8)

  Omar, 2007\[[@pone.0194235.ref054]\]                                         Case report                                                            **Chronic WADIII**(6 months)                                           30 year old male                                             N = 1                                                      • Clinical examination.\                                                                    **Left brachial plexus lesion**\
                                                                                                                                                                                                                                                                                                                                                     • MRI\                                                                                      • Denervation of L serratus anterior and reduced motor unit recruitment (Winging scapular)
                                                                                                                                                                                                                                                                                                                                                     • Electromyography\                                                                         
                                                                                                                                                                                                                                                                                                                                                     • Nerve conduction studies                                                                  

  Sterling 2002 \[[@pone.0194235.ref055]\]                                     Case control                                                           **Chronic WADII & III**\>3months                                       **WAD**\                                                     WAD N = 156                                                Clinical examination                                                                        **Brachial plexus provocation test**\
                                                                                                                                                                                                                             • Mean (SD) 37.43 (9.3) yearsFemale n = 127\                                                                                                                                                                        **ROM** (from -180degrees) Mean (95%CI)\
                                                                                                                                                                                                                             • Male n = 29\                                                                                                                                                                                                      • WAD -26.21 (-28.05, -24.37)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control -12.92 (-15.24, -10.6)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **VAS (0--10)**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD 4.93 (4.6, 5.3)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control 2.62 (2.2, 3.04)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **WAD vs control**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Significantly higher VAS and less ROM on elbow extension in WAD group (p\<0.001)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Subgroups within WAD:**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Group 1: Whole arm pain reproduced with BPPT n = 40\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Group 2: Arm pain not reproduced with BPPT n = 54\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Group 3: No arm pain n = 62\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Elbow extension significantly less in group 1 then group 2\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Elbow extension significantly less and VAS significantly higher in group 1 vs group 3\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 No difference in ROM or VAS between group 2 and 3

  **Control**\                                                                 Control N = 95                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) 38.95 (14.47) years\                                                                                                                                                                                                                                                                                                                                                                                                                 
  • Female n = 50\                                                                                                                                                                                                                                                                                                                                                                                                                               
  • Male n = 45                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Sterling 2003a \[[@pone.0194235.ref056]\]                                    Case control                                                           **WADII-III** (\< 1 month)                                             **WAD**\                                                     WAD N = 66\                                                • Clinical examination\                                                                     **SCM activity**\
                                                                                                                                                                                                                             Mean (SD) 36.27 (12.69) years\                                                                                          • Electromyography                                                                          Increased SCM muscle activity across all point and disability ratings with higher disability resulting in heighten SCM activity\
                                                                                                                                                                                                                             • Female n = 45\                                                                                                                                                                                                    • **Recovered group** n = 25, NDI\<8, 29±4%\
                                                                                                                                                                                                                             • Male n = 21\                                                                                                                                                                                                      • **Mild pain and disability** n = 22 NDI 10--28, 27±3%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Moderate/severe pain and disability** n = 19, NDI \>30, 40±4%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Control** n = 20, 16±3%

  **Control**\                                                                 Control N = 20                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) 40.1 (13.6) years\                                                                                                                                                                                                                                                                                                                                                                                                                   
  • Female n = 12\                                                                                                                                                                                                                                                                                                                                                                                                                               
  • Male n = 8                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Sterling 2003b(?same as 2003a)\[[@pone.0194235.ref057]\]                     Case control                                                           **Sub-acute WADII-III**                                                **WAD**\                                                     WAD N = 80\                                                Clinical examination                                                                        **BPTT (from 180-degree extension elbow)**\
                                                                                                                                                                                                                             Mean (SD) 36.27 (12.69) years\                                                                                                                                                                                      • **\<1 months post injury**\
                                                                                                                                                                                                                             • Female n = 56\                                                                                                                                                                                                    • **Recovered group** -23.95 (2.4) degrees, VAS 1.8 (04)\
                                                                                                                                                                                                                             • Male n = 24\                                                                                                                                                                                                      • **Mild pain** -33.97 (2.6) degrees, VAS 3.2 (0.5)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Moderate/severe pain** -34.27 (3.4) degrees, VAS 4.1 (0.5)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Control** -20.67 (3.12) degrees, VAS 1.8 (04)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Mild pain** recovered and no different from controls at 2 months\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **6 months**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Moderate/severe pain:** continued to have higher VAS 3.4 (1.0) and reduced elbow extension (no data provided)

  **Control**\                                                                 Control N = 20                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) 40.1 (13.6) years\                                                                                                                                                                                                                                                                                                                                                                                                                   
  • Female n = 12\                                                                                                                                                                                                                                                                                                                                                                                                                               
  • Male n = 8                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Sterling 2004 \[[@pone.0194235.ref012]\]                                     Case control                                                           **Acute WADII-III**\<1 month                                           **WAD**\                                                     WAD N = 80\                                                • Clinical examination\                                                                     **SCM activity (%)**\
                                                                                                                                                                                                                             Mean (SD) 33.5 (14.7) years\                                                                                            • Electromyography                                                                          • **Control** 13(3)%\
                                                                                                                                                                                                                             • Female n = 56\                                                                                                                                                                                                    • **Mild** 32(3)%\
                                                                                                                                                                                                                             • Male n = 24\                                                                                                                                                                                                      • **Moderate** 29(4)%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Severe** 47(4)%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **BPTT \[mean (SD) from 180-degree extension elbow + VAS mean (SD)\]**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Control** -21.4 (10.8), VAS 1.7 (1.7)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Mild** -26.7 (17.7), VAS 1.8 (1.7)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Moderate** -31.3 (14.9), VAS 3.0 (1.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • **Severe** -36.5 (11.8), VAS 4.3 (1.6)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Significantly decreased elbow extension ROM and higher VAS in severe pain group versus the other 2 whiplash groups

  **Control**\                                                                 Control N = 20                                                                                                                                                                                                                                                                                                                                                    
  Mean (SD) 39.5 (14.6) years\                                                                                                                                                                                                                                                                                                                                                                                                                   
  • Female n = 11\                                                                                                                                                                                                                                                                                                                                                                                                                               
  • Male n = 9                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Sterling 2005 (same population 2004)\[[@pone.0194235.ref058]\]               Cohort                                                                 **Chronic WADII-III** (96% WAD II)                                     **WAD**\                                                     N = 80                                                     Clinical examination                                                                        **Thoracic pain prevalence** 54%
                                                                                                                                                                                                                             Mean (SD) 36.27 (12.69) years\                                                                                                                                                                                      
                                                                                                                                                                                                                             Female n = 56                                                                                                                                                                                                       

  Sterling 2009 \[[@pone.0194235.ref059]\]                                     Cohort                                                                 **Acute WADI-III**                                                     **WAD**\                                                     N = 85                                                     Clinical examination                                                                        **BPTT (from 180-degree extension elbow, mean (SD))**\
                                                                                                                                                                                                                             Mean (SD) 36.27 (12.69) years\                                                                                                                                                                                      • S-LANSS \>12 n = 29--56.5 (28)\
                                                                                                                                                                                                                             Female n = 54                                                                                                                                                                                                       • S-LANSS \<12 n = 56--35.3 (19)

  Wenzel 2009\[[@pone.0194235.ref060]\]                                        Case control                                                           **Chronic WAD**(94% \>2 years)                                         **WAD**\                                                     WAD N = 785\                                               Questionnaire and clinical examination                                                      **Control group** n = 2.060 (0.3%)\
                                                                                                                                                                                                                             Mean (SD) 47.6 (14.9)\                                                                                                                                                                                              **CWAD** n = 117 (41%)\
                                                                                                                                                                                                                             Female 48.4%\                                                                                                                                                                                                       Odds ratio (95% confidence interval) 7.84 (6.26--9.82)

  **Control**\                                                                 Control N = 52,208                                                                                                                                                                                                                                                                                                                                                
  Mean (SD) 47.9 (16.7)\                                                                                                                                                                                                                                                                                                                                                                                                                         
  Female 50.7%                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Wirth2014 \[[@pone.0194235.ref061]\]                                         Case control                                                           **Chronic WAD**                                                        WAD\                                                         N = 7 (sub set from larger cohort of neck pain patients)   Clinical examination                                                                        **Thoracic neutral posture and mobility** (raw data provided by authors)\
                                                                                                                                                                                                                             Mean (SD) age 45 (10.03) years\                                                                                                                                                                                     **WAD**\
                                                                                                                                                                                                                             Females n = 4\                                                                                                                                                                                                      • Thoracic neutral 30.14 (12.86) degrees\
                                                                                                                                                                                                                             Males n = 3                                                                                                                                                                                                         • Thoracic flexion-extension 50 (14.55) degrees\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Chest expansion axilla 4.72 (2.53) cm\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Chest expansion xiphoid 5.21 (2.92) cm\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Control**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Thoracic neutral 36.75 (11.32) degrees\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Thoracic flexion-extension 43.76 (16.09) degrees\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Chest expansion axilla 5.86 (2.34)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Chest expansion xiphoid 5.75 (2.33)

  Yeung 1997 \[[@pone.0194235.ref062]\]                                        Case control                                                           **WAD** \<12mths(**suggestive WADI or II**)                            **WAD**\                                                     WAD N = 20\                                                Clinical examination                                                                        **Stage1:**\
                                                                                                                                                                                                                             Mean 25.3 years\                                                                                                                                                                                                    • WAD n = 12 (60%),\
                                                                                                                                                                                                                             Female n = 20\                                                                                                                                                                                                      • Control n = 2 (5%) (n = 8 of WAD group reported mid-thoracic symptoms)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Stage2:**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 WAD (90%),\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Control n = 26 (65%) reported symptoms\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 (WAD n = 15 (75%), Control n = 23 (57.5%) reported mid-thoracic symptoms\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Stage 3:**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Pain response in both groups mid-thoracic\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Stage 4:**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD n = 17 (85%) reported mid-thoracic symptoms\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control n = 33 (82.5%) reported mid-thoracic symptoms\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Stage 5:**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Evidence of greater proportion of mid-thoracic pain reduction in WAD group compared to control.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Stages 6, 7:**\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • no data\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 Mean (SD) ROM degrees\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • Control L 74 (3.82), R 74 (4.57)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                 • WAD L 68 (3.3), R 68 (4.60)

  Control\                                                                     Control N = 40                                                                                                                                                                                                                                                                                                                                                    
  Mean 24.0 years\                                                                                                                                                                                                                                                                                                                                                                                                                               
  Female n = 40\                                                                                                                                                                                                                                                                                                                                                                                                                                 
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AIS: Abbreviated Injury Scale BPI: brachial plexus irritation, BPTT: brachial plexus tension test, CCFT: craniocervical flexion test, CT: computerised tomography, EMG: electromyography, MRI: magnetic resonance imaging, MTP: myofascial trigger point, NBPI: no brachial plexus irritation, NDI: Neck Disability Index, NRS: numerical rating scale, OR: odds ratio, RCT: randomised controlled trial, ROM: range of movement, SCM: sternocleidomastoid muscle, TOS: thoracic outlet syndrome, TDH: thoracic disc herniation, WAD: whiplash associated disorders, WDQ: Whiplash Disability Index

10.1371/journal.pone.0194235.t002

###### Overview of included studies.
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  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author\                                              Measurement and summary outcome                                                                                         Sample size n =                               Acute/\     Chronic   WADI/II     WADII        WADII/III
  N = 37 papers                                                                                                                                                                                                              sub acute                                      
  ---------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- --------------------------------------------- ----------- --------- ----------- ------------ -----------
                                                       **Thoracic pain prevalence**                                                                                                                                                                                         

  Yeung 1997                                           75% (during slump)                                                                                                      20                                                        x         x?                       

  Koelbeck 1999                                        No difference light touch (reduced PPT, hyperalgesia & referral)                                                        11                                                        x                     x            

  Bergland 2001                                        15.3%                                                                                                                   242                                                       x         x (minor)                

  Hartling 2002                                        74%                                                                                                                     380                                           x                     x                        x

  Bock 2005                                            71% (allodynia)                                                                                                         22                                                        x         x                        

  Sterling 2005                                        54%                                                                                                                     [\*\*\*](#t002fn004){ref-type="table-fn"}76               x                                  x

  Holm 2007                                            Acute 52%, chronic 80%                                                                                                  56                                            x           x                                  

  Wenzel 2009                                          41%                                                                                                                     785                                                       x                                  

  Hincapie 2010                                        66--75%                                                                                                                 6481                                          x                                              

  Myran 2011                                           7--8.8%                                                                                                                 46,895                                                    x                                  

  Bortsov 2014                                         47%                                                                                                                     [\*](#t002fn002){ref-type="table-fn"}948      x                     x                        

  *Cornips 2014*                                       *Pain associated with herniated disc 4/10*                                                                              *10*                                                      *x*                                

  McLean 2014                                          21% (upper thoracic/shoulder 23%)                                                                                       711                                           x                     x                        

  Johansson 2015                                       43%                                                                                                                     3711                                          x           ?                                  

                                                       **Chest pain prevalence**                                                                                                                                                                                            

  Holm 2007                                            Acute 0%, chronic 6%                                                                                                    56                                            x           x                                  

  Hincapie 2010[\*](#t002fn002){ref-type="table-fn"}   19%                                                                                                                     *6481*                                        x                                              

  Myran 2011                                           6.9--7%                                                                                                                 46,895                                                    x                                  

  Bortsov 2014[\*](#t002fn002){ref-type="table-fn"}    19%                                                                                                                     *948*                                         x                     x                        

  McLean 2014[\*](#t002fn002){ref-type="table-fn"}     8%                                                                                                                      *948*                                         x                     x                        

                                                       **Thoracic posture & mobility**                                                                                                                                                                                      

  Kall 2008                                            Flexion hypomobility                                                                                                    47                                            x                     x                        x

  Helgadottir 2011a                                    No change                                                                                                               23                                                        x                     x            

  Wirth 2014                                           Reduced kyphosis (chest expansion)                                                                                      7                                                         x                                  

                                                       **Thoracic outlet syndrome prevalence**                                                                                                                                                                              

  Capistrant 1976                                      86%                                                                                                                     35                                                        x                                  

  Capistrant 1986                                      36%                                                                                                                     111                                                       x?                                 

  Magnusson 1994                                       32%                                                                                                                     38                                                        x         x                        x

  Kai 2001                                             74%                                                                                                                     110                                                                                          

  Alexandre 2005                                       Positive                                                                                                                24                                                        x         x (mild)                 

                                                       **Brachial Plexus test**                                                                                                                                                                                             

  Ide 2001                                             Prevalence 38%                                                                                                          119                                           x           x                                  

  Sterling 2002                                        Positive                                                                                                                156                                                       x                                  x

  Sterling 2003b                                       Positive                                                                                                                [\*\*](#t002fn003){ref-type="table-fn"}80     x           x                                  x

  Sterling 2004                                        Positive                                                                                                                80                                            x                                              x

  *Omar 2007*                                          *Brachial plexus lesion*                                                                                                *1*                                                       *x*                                *x*

  Chien 2009                                           Positive                                                                                                                31                                                        x                     x            

  Sterling 2009                                        Positive                                                                                                                85                                            x                                              x

  Ferrari 2010                                         Positive                                                                                                                69                                            x                     x                        

                                                       **Muscle activation**                                                                                                                                                                                                

  *Bodack 1998*                                        *Weak mid and lower trapezius*                                                                                          *1*                                           *x*                                            *x*

  Klein 2001                                           SCM muscle activation: normal                                                                                           46                                                        x                     x (mainly)   

  Sterling 2003a                                       SCM muscle activity heightened                                                                                          [\*\*](#t002fn003){ref-type="table-fn"}66     x                                              x

  Sterling 2004                                        SCM muscle activity heightened                                                                                          [\*\*\*](#t002fn004){ref-type="table-fn"}80   x                                              x

  Helgadottir 2011b                                    Serratus anterior activation: delayed onset and reduced duration of activation. No change for lower and mid trapezius   27                                                        x                     x            

                                                       **Muscle pain and trigger points**                                                                                                                                                                                   

  Bismil 2005                                          Mid/Low trapezius enthesopathy (myofascial pain +TP) 48%                                                                25                                                        x                     x            

  Ettlin 2008                                          SCM and Scaleneus medius MTP prevalence 24%, 30%                                                                        47                                                        x                                  

  Fernandez-de-las-Perez 2012                          SCM and Scaleneus medius MTP                                                                                            20                                            x                                 x            

  Castaldo 2014                                        SCM Latent and active TP                                                                                                49                                                        x         x (mild)                 x
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note

\*Same population

\*\* same population

\*\*\* same population

SCM: sternocleidomastoid muscle

Risk of bias within studies {#sec023}
---------------------------

Agreement of risk of bias following discussion was excellent with studies ranging considerably in quality from 1/9 to 7/9. Key methodological flaws included poor definition of cases, representativeness of cases, lack of non-exposed cohort, lack of blinding, controlling for risk factors beyond age and gender and clarity of follow up time point in cohort studies. There were many instances where information was missing and email requests for additional data or clarification was unforthcoming, resulting in ratings being 'unclear'. See [Table 3](#pone.0194235.t003){ref-type="table"} for risk of bias for cohort studies and [Table 4](#pone.0194235.t004){ref-type="table"} for case control studies.

10.1371/journal.pone.0194235.t003

###### Risk of bias assessment: Thoracic dysfunction in whiplash associated disorders: A systematic review and meta-analysis cohort studies.
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  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author           Dysfunction & sample size               Classification and time post injury\        Summary results                                                                                 Quality                                                Comments/study quality                                                                                                                                                                                                                                                                                                      
                                                           Disability\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                           Pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  ---------------- --------------------------------------- ------------------------------------------- ----------------------------------------------------------------------------------------------- ------------------------------------------------------ ------------------------ --------------------------------------------------------------- ------------------------------------ --------------------------------------------- --------------------------------------------------- ------------------------------------------------- --------------- ------------------------- ------------------------------------------------------------------------------
  Alexandre 2005   Thoracic outlet syndrome\               Mild\                                       Brachial plexus entrapment due to TOS                                                           No\                                                    No non exposed cohort    Yes\                                                            Yes\                                 No                                            No                                                  Yes\                                              Yes             Unclear                   Mild, but with neurological deficits?\
                   N = 24                                  Mean (range) 11 (2--48) mths                                                                                                                Sub group cervical spine injury included\                                       Patient examination and ED documents                            Exclusion criteria provided                                                                                                            Medical tests: NCS                                                                          Conservative management prior to examination\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Post injury period variable\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          All patients offered surgery

  Bismil 2012      Trapezius dysfunction\                  WADII\>6mths, but not reported              Trapezius myofascial-entheseal dysfunction\                                                     Yes                                                    No\                      Yes\                                                            No\                                  No\                                           No                                                  No                                                Yes             Unclear                   Clinical examination in medico legal practice\
                   n = 25\                                                                             Enthesopathy (myofascial pain and trigger points)                                                                                                      non exposedcohort        Patient examination                                             Not reported                         Not reported                                                                                                                                                                                  Limited sample details\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Limited information on examination and outcome measures

  Bock 2005        Thoracic allodynia\                     WADI & II3-18 mths                          Thoracic allodynia evident in 70.97%\                                                           Yes\                                                   No non exposed cohort    Yes\                                                            Yes\                                 No\                                           Unclear\                                            Yes                                               Yes\            No\                       Aim focus to reliability of measures
                   N = 22                                                                              (more in lower spinal segments, T8,9,10)                                                                                                                                        Recruitment from private 'physiatry'/pain management practice   Clear exclusion criteria             Wide age range (wider with male population)   Exclusion criteria controlled other risk factors?                                                     No follow up?   No follow up              

  Bortsov 2014     Thoracic pain\                          WADI & II\                                  Thoracic and chest pain prevalence at 6 weeks 47% and 19% respectively                          Yes                                                    No non exposed cohort    Yes\                                                            Unclear\                             Yes\                                          Unclear                                             Yes\                                              Yes             Yes                       Recruitment from ED\
                   N = 948                                 6 weeks, 3,6,12 mths\                                                                                                                                                                                                       ED department interview                                         No reference to prior msk injury     Adjusted for age and sex                                                                          Range of approaches                                                                         Limited upper back data: included within axial data\
                                                           NRS6 weeks 3.8 (2.8)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Selective reporting of results: timepoints, regions
                                                           6 months 3.1 (2.8)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                           1 year 3.2 (2.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Capistrant1976   Thoracic outlet syndrome\               Unknown\                                    Thoracic outlet syndrome n = 30/35 (86%)                                                        No\                                                    No non exposed cohort    Yes\                                                            No\                                  No\                                           No                                                  Yes\                                              Yes             Unclear                   Private neurological practice\
                   N = 35                                  Acute: 3.5 mths (max 8mths)\                                                                                                                With signs of TOS. Unclear re stage & severity                                  Private neurological practice.                                  Not reported                                                                                                                           NCS records                                                                                 Clarity re stage and WAD classification\
                                                           Chronic: mean 29mths (inc n = 1 16 years)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Inconsistent follow up periods\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Not accounted for other variables

  Capistrant1986   Cervical Strain injuries\               Unknown? Chronic\                           Thoracic outlet syndrome prevalence 36%                                                         No\                                                    No non exposed cohort    Yes\                                                            No\                                  No                                            No                                                  Yes\                                              Yes             Unclear                   Clarity re stage and WAD classification\
                   N = 111\                                24month period                                                                                                                              Selected for presentation                                                       Private neurological practice.                                  Not reported                                                                                                                           NCS records                                                                                 Variable follow up periods\
                   Of whom N = 40 was TOS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Not accounted for other variables\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Limited details of sample, follow up

  Ferrari 2010     Brachial plexus\                        WADI & II\                                  Brachial plexus provocation test                                                                Yes\                                                   No non exposed cohort    Yes\                                                            Yes\                                 No                                            No                                                  Unclear\                                          Yes             Yes\                      Clear recruitment, reporting attrition and sample details. Prognostic study\
                   N = 69                                  \<1 week and chronic (3 months)\                                                                                                            Acute WAD                                                                       GP referral and assessment by specialist researcher             Clear exclusion criteria                                                                                                               Researcher performed measurements (no blinding)                   2 loss to follow up       Incomplete data for all time points: baseline BPTT omitted
                                                           WDQ 64 (23) VAS 2.2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Hartling2002     Upper back pain\                        Sub-acute WADI-III                          Upper back pain 74.6%                                                                           Yes\                                                   No non exposed cohort    Yes\                                                            Yes\                                 No                                            No                                                  Unclear                                           Yes             Yes\                      Derivation of a clinical prediction rule study rather than cohort
                   N = 380                                                                                                                                                                             From earlier paper                                                              From ED                                                         From earlier paper                                                                                                                                                                                       87.9% follow up           

  Holm2007         Upper back pain\                        Acute-chronic WAD                           Chest pain prevalence\                                                                          No\                                                    No non exposed cohort    No\                                                             Unclear\                             Yes                                           No                                                  Unclear\                                          Yes             Yes\                      Insurance claimants or filed claim
                   N = 56                                                                              Acute 0%\                                                                                       Claimants                                                                       Claimants                                                       No information                                                                                                                         Questionnaire                                                     63% for all time points   
                                                                                                       Chronic (6 weeks) 6%\                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                       Thoracic pain prevalence\                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                       Acute 52%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                       Chronic 80%                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Hincapie2010     Thoracic pain\                          WADI, II\                                   Thoracic pain prevalence 65.5--75.3%\                                                           No\                                                    No non exposed cohort    Unclear\                                                        No                                   No\                                           No                                                  Unclear\                                          Yes\            Yes\                      Insurance claimants\
                   N = 6481                                \<30 days post traffic injury               Chest painprevalence18.9%                                                                       Litigants                                                                       Self-Report to insurance company                                                                     Age 18yrs or older                                                                                Self-report/ pain drawings                        No follow up?   No follow up?             Analysed pain drawings linked to pre-existing symptoms- no data reported

  Ide2001          Brachial plexus irritation\             WAD1week to 6 months                        Brachial plexus irritation prevalence n = 45/74 (61%) (associated with poor outcome)            Unclear                                                No non exposed cohort    Yes                                                             No                                   No\                                           No                                                  No                                                Yes             Yes\                      Details of recruitment unclear\
                   N = 119                                                                                                                                                                                                                                                                                                                                                                  Was gender controlled? M = 59 vs W = 60                                                                                                                             2 loss to follow up       Clarity re stage and WAD classification\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          More females in BPI group\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Wide age range\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Assessor blinding unclear\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Loss to follow up unclear

  Johansson2015    Thoracic pain\                          WAD\<42 days post injury when claim filed   Thoracic spine pain 43%\                                                                        No\                                                    No non exposed cohort    Yes\                                                            Unclear                              Unclear\                                      No                                                  Yes\                                              Yes             Yes\                      Data for different time points not provided
                   N = 3711                                                                            Baseline pain rating 6 (5--8)\                                                                  Canadian provincial population                                                  Registered health care professional                                                                  Data provided for sub groups                                                                      Independent research centre                                       90% follow up             
                                                                                                       23% not recovered after one year                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Kai2001          Thoracic outlet syndrome\               WAD                                         Neurogenic thoracic outlet syndrome prevalence\                                                 Unclear\                                               No non exposed cohort    Yes                                                             Unclear\                             No                                            No                                                  No                                                Unclear         Unclear                   Details of recruitment unclear\
                   N = 110                                                                             n = 81/110 (74%)                                                                                Clarity re stage and WAD classification                                                                                                         Not explicit re exclusion criteria                                                                                                                                                                                                 Sample details unclear\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Assessor blinding unclear\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Loss to follow up unclear\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Some had surgery

  Kall2008         Cervico-thoracic mobility\              WADI-III\                                   Concluded women with sub-acute WAD C7-T1 flexion hypomobility                                   Yes\                                                   No non exposed cohort    Yes\                                                            Yes\                                 No                                            Unclear                                             No                                                Yes             Unclear                   Details of recruitment suggest self-selection into trial\
                   N = 47                                  (sub-acute)                                                                                                                                 Self-selection                                                                                                                                  Clear eligibility criteria                                                                                                                                                                                                         Sample details unclear

  Magnusson1994    Thoracic outlet syndrome\               Chronic WADI-III\                           Thoracic outlet syndrome prevalence 31.6%                                                       No\                                                    No non exposed cohort    Yes\                                                            Yes\                                 No                                            No                                                  No                                                Yes             Unclear                   Details of recruitment unclear\
                   N = 38                                  Mean (range) 17 (6--44) months                                                                                                              Some had surgery                                                                Interviewed by author                                           Clear eligibility criteria                                                                                                                                                                                                         Late whiplash\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sample details unclear\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Some had surgery

  McLean2014       Thoracic, chest pain\                   Acute WAD\                                  Thoracic pain prevalence 21%, shoulder 23%, chest 8%                                            No\                                                    No non exposed cohort    Yes\                                                            Unclear\                             Yes\                                          Unclear                                             Yes                                               Yes             Yes                       Non litigant population\
                   N = 948                                 WADI & II\                                                                                                                                  English speakers, non-Hispanic white population only                            ED department interview                                         No reference to prior msk injury     Adjusted for age and sex                                                                                                                                                                      Clear eligibility criteria\
                                                           24 hours to 6 weeks                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Only individuals from ED\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Payment for participation

  Myran2011        Upper back and chest pain prevalence\   WAD\                                        Chest/abdomen pain prevalence\                                                                  No\                                                    No non exposed cohort    Unclear\                                                        Unclear\                             Yes\                                          Yes                                                 Unclear                                           Yes             N/A                       Non litigant population\
                   N = 46,895                              No other details                            Men 7%\                                                                                         Norwegian population                                                            Questionnaire as part of health survey                          No reference to prior msk injury     Adjusted for age and sex                                                                                                                                                                      Clear eligibility criteria\
                                                                                                       Women6.9%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Only individuals from ED\
                                                                                                       Upper back pain prevalence\                                                                                                                                                                                                                                                                                                                                                                                                                                                        Payment for participation
                                                                                                       Men 8.8%\                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                       Women 7.0%                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Sterling 2005    Thoracic pain\                          WADII-III\                                  Thoracic pain prevalence 54%                                                                    Yes                                                    No non exposed cohort    Yes\                                                            Yes\                                 Yes                                           Yes\                                                Unclear                                           Yes             Yes\                      Recruited primary care, ED and community\
                   N = 76                                  6 months\                                                                                                                                                                                                                   Recruited primary care, ED and community                        Clear exclusion criteria                                                           Controls for other factors in analysis                                                                                Loss to follow up n = 4   Clear eligibility criteria\
                                                           NDI 34.15 (2.37)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Assessor blinding unclear\
                                                           VAS3.5 (1.2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Loss to follow up suggested 4/80, but numbers unclear

  Sterling 2009    Brachial plexus\                        Acute WADII-III\                            Brachial plexus provocation test positive (and associated with neuropathic pain presentation)   Yes\                                                   No non exposed cohort    Yes\                                                            Yes\                                 Unclear                                       Unclear                                             Unclear                                           Yes             Unclear                   Recruited primary care, ED and community\
                   N = 85                                  2.6 (1.2) weeks                                                                                                                             Acute                                                                           Recruited primary care, ED and community                        Clear exclusion criteria                                                                                                                                                                                                           Assessor blinding unclear\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          No mention of any losses to follow up.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Control for age and gender unclear
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0194235.t004

###### Risk of bias assessment: Thoracic dysfunction in whiplash associated disorders: A systematic review and meta-analysis case control studies.
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  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                Dysfunction & sample size                                     Classification and time post injury\                                           Summary results                                                                                                                    Quality                                                         Comments/study quality                                                                                                                                                                                                                                
                                                                                      Pain duration, disability and pain intensity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  --------------------- ------------------------------------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------- --------------------------- --------------------------- ------------------------------------------------- ----------------------------------------- ---------------- ------------------------------------------------ ----- ------------------------- --------------------------------------------------------------
  Berglund 2001         Thoracic pain\                                                Mild\                                                                          Thoracic pain prevalence\                                                                                                          Unclear\                                                        No\                         Yes                         No\                                               Yes\                                      No               Yes\                                             Yes   Yes\                      No patient demographics Funded by insurance company
                        N = 242                                                       7 years                                                                        15.3%                                                                                                                                                                                              Litigant population                                     ? prior injuries not accounted for                Chosen based on age & sex                                  Questionnaire                                          \~77%                     

  Castaldo2014          Myofascial trigger points\                                    WADII & III\                                                                   SCM Myofascial trigger points (latent & active)                                                                                    Yes\                                                            Yes                         Unclear\                    Yes                                               Yes\                                      Yes\             Unclear                                          Yes   n/a                       Compared with MNP\
                        N = 49                                                        Mean (SD) 57.12 (14.11) mths\                                                                                                                                                                                     Screen by physician                                                                         From same location as WAD                                                     Matched age & sex                         Gps comparable                                                                                    Not clear re centre for recruitment\
                                                                                      VAS 5.59 (0.42)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Inc/exclusion criteria clear

  Chien 2009            BPPT\                                                         WADII\                                                                         Brachial plexus provocation test positive in WAD                                                                                   Unclear\                                                        Yes\                        Yes\                        Yes\                                              Yes\                                      No               Unclear\                                         Yes   Unclear                   Other factors not controlled for e.g. psychological factors\
                        N = 31                                                        16 (11) months post injury\                                                                                                                                                                                       Primary care and media                                          WADII                       Community                   Never experienced cervical pain or trauma         Matched age & sex                                          No information                                                                   WAD group moderate disability
                                                                                      NDI 45.9 (18.8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Ettlin2008            Myofascial trigger points\                                    Unknown\                                                                       Scaleneus medius and SCM myofascial trigger points                                                                                 No                                                              Unclear                     Yes\                        Unclear                                           No\                                       No               Yes\                                             Yes   Unclear                   Controls recruited from one of the sites\
                        N = 47                                                        Mean (SD) 1.47 (1.8) years\                                                                                                                                                                                                                                                                                   Same site                                                                     Similar age, but not gender                                Blinded assessor                                                                 Unclear re sample characteristics\
                                                                                      VAS 5.42 (2.08)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         More females in WAD group\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              WAD participants had physiotherapy

  Fernandez-Perez2012   Myofascial trigger points\                                    WADII\                                                                         Scalene and SCM myofascial trigger points                                                                                          Yes\                                                            Yes\                        Yes\                        Unclear\                                          Yes\                                      Yes              Yes\                                             Yes   n/a                       Other factors not controlled for e.g. psychological factors\
                        N = 20                                                        Mean (SD)26.6 (3.8) days\                                                                                                                                                                                         Referred by physician                                           WADII severe disability     General population          No reference to previous WAD                      Matched age & sex                                          Blinded assessor                                                                 WAD group severe disability\
                                                                                      NDI 68.5 (8.7)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                      VAS 6.2 (2.6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Helgadottir2011a      Thoracic Alignment (mid thoracic curve)\                      WADII\                                                                         Thoracic alignment (posture) no change                                                                                             No\                                                             Yes\                        No\                         Unclear\                                          Yes                                       Yes              No\                                              Yes   Unclear                   VAS not provided although included\
                        N = 23                                                        \>6months\                                                                                                                                                                                                        Self-selected                                                   WADII                       Convenience sample          Current history only                                                                                         Clear procedure                                                                  Recruitment of control unclear
                                                                                      NDI = 38 (18.75)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Helgadottir2011b      Muscle function (mid & lower trapezius, serratus anterior)\   WADII\                                                                         Delayed onset and duration of serratus anterior muscle activation                                                                  Yes\                                                            Yes\                        No\                         Unclear\                                          Yes                                       Yes              No\                                              Yes   Unclear                   No reference to blinding\
                        N = 27                                                        \>6monthsNDI\>10\                                                                                                                                                                                                 Physio screened                                                 WADII\                      Convenience sample          Current history only                                                                                         Clear procedure                                                                  VAS not provided\
                                                                                      NDI 38 (18) VAS 6 (2)                                                                                                                                                                                                                                                             NDI\>10                                                                                                                                                                                                                                               Recruitment of control unclear

  Klein2001             Muscle activation sternocleidomastoid\                        Chronic WADI-III\                                                              No evidence of earlier SCM activation during axial rotation                                                                        Yes\                                                            Unclear\                    No\                         No\                                               Unclear\                                  No               No\                                              Yes   Unclear                   Recruitment of controls unclear\
                        N = 46                                                        33.7 (26.7) months                                                                                                                                                                                                GP referral                                                     No sure re classification   Convenience sample          Some controls had pre-existing neck complaints\   Age adjusted for in analysis?                              Clear procedure                                                                  Controls younger than WAD\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              WAD group 33% men, control 42%)

  Koelbeck1999          Pain over infraspinatus region\                               Chronic WADII\                                                                 Reduced pressure pain threshold in WAD: muscle hyperalgesia and diffuse pain referral                                              Yes\                                                            Yes\                        No                          Yes\                                              Yes\                                      No               No\                                              Yes   Unclear                   Recruitment from pain centre\
                        N = 11                                                        Mean (range) duration 4 years, 5 months (1 year, 1month to 7 years 5months)\                                                                                                                                      Referral to pain clinic                                         WADII                                                   No history of musculoskeletal pain conditions     Matched age & sex                                          Clear procedure                                                                  Control recruitment unclear
                                                                                      VAS 5.2 (0.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Sterling 2002         Brachial plexus\                                              Chronic (\>3mths) WAD II &III\                                                 Brachial plexus provocation test positive in WAD                                                                                   Unclear\                                                        Yes\                        Yes\                        Yes\                                              No\                                       No               No\                                              Yes   Unclear                   Time following injury unclear\
                        N = 156                                                       Unclear                                                                                                                                                                                                           Referral to research centre.                                    WADII or III                Community                   Never experienced cervical pain or trauma         Gender imbalance, but analysis adjusted                    No information                                                                   No reference to blinding\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Clinical examination done.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              No independent validation

  Sterling 2003a        SCM activity\                                                 WADII & III1-3 months\                                                         SCM activity increased in those with mod/severe symptoms\>mild\>recovered and controls: over tome points to 3 months post injury   Unclear\                                                        Yes\                        Yes\                        Yes\                                              Yes                                       Yes              No\                                              Yes   Unclear\                  No reference to blinding\
                        N = 66                                                        NDI from 3.00--47.9                                                                                                                                                                                               A&E, community, primary care. No reference to primary records   WADII or III                Community                   Never experienced cervical pain or trauma                                                                    No information                                         No information provided   Control for other psychological variables

  Sterling 2003b        BPTT\                                                         Sub-acute WADII-III                                                            BPTT: those with positive test within 1 mth of injury higher pain levels at 6 mths                                                 Unclear\                                                        Yes\                        Yes\                        Yes\                                              Yes                                       Yes              No\                                              Yes   Unclear\                  No reference to blinding\
                        N = 80                                                                                                                                                                                                                                                                          A&E, community, primary care                                    WADII or III                Community                   Never experienced cervical pain or trauma                                                                    No information                                         No information provided   Control for other psychological variables

  Sterling 2004         SCM activity and BPTT\                                        Acute WADII & III\<1 month\                                                    SCM increased in WAD and with increasing symptom severity\                                                                         Unclear\                                                        Yes\                        Yes\                        Yes\                                              Yes                                       Yes              Unclear\                                         Yes   Unclear                   Blinding unclear
                        N = 80                                                        NDI 15.6--69.5                                                                 BPTT positive in WAD and with increased symptom severity                                                                           A&E, community, primary care                                    WADII or III                Community                   Never experienced cervical pain or trauma                                                                    Blind to subject responses from questionnaires                                   

  Wenzel2009            N = 785                                                       Chronic WAD\                                                                   Thoracic spine pain prevalence 41%                                                                                                 No\                                                             Unclear                     Yes\                        No\                                               Yes                                       No               Unclear\                                         Yes   Unclear                   Large sample as part of health study\
                                                                                      \>2 years                                                                                                                                                                                                         From a wider health study                                                                   Community                   Inc/exc not provided                                                                                         Blind to subject responses from questionnaires                                   Controlling for other variables unclear

  Wirth2014             Chest mobility, Thoracic flexion, extension\                  Chronic WAD\                                                                   Reduced thoracic kyphosis & small reduction in chest expansion                                                                     No\                                                             No                          No                          No\                                               Yes\                                      No               No\                                              Yes   Unclear                   Recruited from sports clubs and medical centres\
                        N = 7                                                         1--5+ years\                                                                                                                                                                                                      Recruited from sports centre                                                                                            Not reported                                      Groups balanced                                            No blinding                                                                      No information re blinding
                                                                                      NDI 12 (7.1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Yeung 1997            Slump\                                                        WAD \<12mths(suggestive WADI or II)\                                           Slump test: positive in all WAD (mid-thoracic pain 75%)                                                                            No                                                              No                          No\                         Yes\                                              Yes                                       No               No\                                              Yes   Unclear                   Only females\
                        N = 20                                                        Unclear                                                                                                                                                                                                                                                                                                       Unclear                     Clear exclusion criteria                                                                                     No blinding                                                                      Unclear recruitment for WAD and control\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Part of a reliability study
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Results of individual studies {#sec024}
-----------------------------

From this review we identified evidence of the following dysfunction,: thoracic spine pain in acute/sub-acute/chronic WAD ranging from minor injuries to more severe (WADIII) presentations \[[@pone.0194235.ref011], [@pone.0194235.ref014], [@pone.0194235.ref017], [@pone.0194235.ref032], [@pone.0194235.ref033], [@pone.0194235.ref043], [@pone.0194235.ref050], [@pone.0194235.ref052], [@pone.0194235.ref058], [@pone.0194235.ref062]\]; chest pain in acute/sub-acute/chronic WAD \[[@pone.0194235.ref011], [@pone.0194235.ref017], [@pone.0194235.ref052], [@pone.0194235.ref053]\]; postural changes \[[@pone.0194235.ref044], [@pone.0194235.ref061]\] and reduced chest/thoracic mobility in CWAD \[[@pone.0194235.ref061]\]; thoracic outlet syndrome in CWAD \[[@pone.0194235.ref031], [@pone.0194235.ref035], [@pone.0194235.ref036], [@pone.0194235.ref047], [@pone.0194235.ref051]\]; involvement of the brachial plexus at all stages and across all levels of WAD severity \[[@pone.0194235.ref012], [@pone.0194235.ref046], [@pone.0194235.ref055], [@pone.0194235.ref057], [@pone.0194235.ref059]\]; muscle dysfunction in the form of the following: 1) heightened activity of the sternocleidomastoid during neck flexion \[[@pone.0194235.ref012], [@pone.0194235.ref056]\], 2) delayed onset of serratus anterior during arm elevation at the chronic stage in mild WAD \[[@pone.0194235.ref045]\] and 3) a high prevalence of myofascial pain and trigger points in the scalene muscles \[[@pone.0194235.ref040], [@pone.0194235.ref041]\], sternocleidomastoid \[[@pone.0194235.ref037], [@pone.0194235.ref040], [@pone.0194235.ref041]\] and mid/lower fibres of trapezius \[[@pone.0194235.ref016]\] within the sub-acute and chronic stages and across different levels of severity.

Synthesis of results {#sec025}
--------------------

Synthesis of findings from cohort and case control studies across outcomes of dysfunction are provided in Tables [5](#pone.0194235.t005){ref-type="table"}--[8](#pone.0194235.t008){ref-type="table"}. Sub-grouping according to stages and defined populations are included where reported. A summary of overall quality is provided based on GRADE following appraisal of risk of bias, consistency, precision, directness and effect size. Clinical heterogeneity across samples with respect to severity of presentation, time post injury and outcomes precluded meta-analysis being performed. Few studies stated a primary aim which accurately reflected the aims and objectives of this review.

10.1371/journal.pone.0194235.t005

###### Pain.

![](pone.0194235.t005){#pone.0194235.t005g}

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                                    Studies                                                   Findings Prevalence % (95% confidence interval) unless stated   Studies                                   Overall GRADE
  ---------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------- ----------------------------------------- -----------------------------------------------------------------------
  **Thoracic spine pain in acute/sub-acute WAD**\            Bodack 1998                                               -Positive                                                       6 cohort,\                                Very low---due to risk of bias, directness and precision
  N = 11,577                                                                                                                                                                           1 single case study                       

  Hartling 2002                                              -Upper back pain 74.6%                                                                                                                                              

  Holm 2007                                                  -52%                                                                                                                                                                

  Hincapie 2010                                              -Mid back 65.5 (64.4--66.7)\                                                                                                                                        
                                                             -Upper thoracic 75.3 (74.3--76.4)                                                                                                                                   

  ^a^ Bortsov 2014 (Mild)                                    -Mid back 47% (18% widespread, 29% localised)                                                                                                                       

  ^a^ McLean 2014 (WADI/II) (moderate or severe pain NRS4)   -Mid back 21% (range 18--24%)\                                                                                                                                      
                                                             -Upper back 23% (range 20--26%)                                                                                                                                     

  Johansson 2015                                             -43%                                                                                                                                                                

  **Thoracic spine pain in chronic WAD**\                    Yeung 1997(?WADI/II)                                      -Slump                                                          5 cohort, 3 case control, 1 case series   Very low---due to risk of bias, precision, consistency and directness
  N = 48,117                                                                                                                                                                                                                     

  Koelbeck 1999 (WADII)                                      -No different controls                                                                                                                                              

  Bergland 2001 (Minor)                                      -15.3% (10.4--21.5)                                                                                                                                                 

  Bock 2005 (WADI/II)                                        -71% (allodynia)                                                                                                                                                    

  Sterling 2005 (WADII/III)                                  -54%                                                                                                                                                                

  Holm 2007                                                  -4months 86%,\                                                                                                                                                      
                                                             -8 months 94%,\                                                                                                                                                     
                                                             -12 months 87%                                                                                                                                                      

  Wenzel 2009                                                -41%                                                                                                                                                                

  Myran 2011                                                 -men 8.8%\                                                                                                                                                          
                                                             -women 7%                                                                                                                                                           

  Cornips 2014                                               10 previously asymptomatic individuals significant pain                                                                                                             

  **Thoracic spine pain in chronic WAD I/II**\               Koelbeck 1999 (WADII)                                     -No different controls                                          3 cohort, 1 case control                  Very low---due to risk of bias, precision, consistency and directness
  N = 655                                                                                                                                                                                                                        

  Bergland 2001 (Minor)                                      -15.3% (10.4--21.5)                                                                                                                                                 

  Hartling 2002                                              -Upper back pain 74.6%                                                                                                                                              

  Bock 2005 (WADI/II)                                        -71% (allodynia)                                                                                                                                                    

  **Thoracic spine pain in chronic WADII/III**\              Sterling 2005 (WADII/III)                                 -54%                                                            1 cohort                                  Low??
  N = 76                                                                                                                                                                                                                         

  **Chest pain in acute/sub-acute WAD**\                     Holm 2007                                                 -0%                                                             4 Cohorts                                 Very low---due to risk of bias, precision, consistency and directness
  N = 7485                                                                                                                                                                                                                       

  Hincapie 2010                                              -localised 0.05 (0.00--0.10)\                                                                                                                                       
                                                             -widespread 18.9 (17.9--19.8)                                                                                                                                       

  aBortsov 2014 (mild)                                       -19% (10% localised\                                                                                                                                                
                                                             -9% widespread)                                                                                                                                                     

  aMcLean 2014 (WADI/II)                                     -8% (6--10%) (moderate or severe pain)                                                                                                                              

  **Chest pain in chronic WAD**\                             Holm 2007                                                 -6-weeks 6%\                                                    2 cohorts                                 Very low---due to risk of bias, precision, directness
  N = 46,951                                                                                                           -4-months 4%\                                                                                             
                                                                                                                       8-months 12%,\                                                                                            
                                                                                                                       -12-months 22%                                                                                            

  Myran 2011                                                 -men 7%, women 6.9%                                                                                                                                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0194235.t006

###### Posture and mobility.

![](pone.0194235.t006){#pone.0194235.t006g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                           Studies                                 Findings                         Grade                           Overall GRADE
  ------------------------------------------------- --------------------------------------- -------------------------------- ------------------------------- ----------------------------------------------------------------------
  **Thoracic posture in chronic WAD**\              Helgadottir 2011a (WADII)               -No change                       2 Case control                  Very low: due to risk of bias, precision, consistency and directness
  N = 30                                                                                                                                                     

  Wirth 2014                                        -Reduced kyphosis                                                                                        

  **Thoracic and chest mobility in chronic WAD**\   Kall 2008                               -Flexion hypomobility in women   1 cohort study,1 case control   Very low: due to risk of bias, precision, consistency and directness
  N = 54                                                                                                                                                     

  Wirth 2014                                        -Reduced chest mobility\                                                                                 
                                                    -Slight increase in thoracic mobility                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

10.1371/journal.pone.0194235.t007

###### Thoracic outlet syndrome and brachial plexus.

![](pone.0194235.t007){#pone.0194235.t007g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                        Studies                                                                                                             Findings \[TOS: Prevalence % (95% confidence interval); Brachial plexus provocation test (BPPT) unless stated\]   Grade                      Overall GRADE
  ---------------------------------------------- ------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- -------------------------- ----------------------------------------------------------------------
  **Thoracic outlet syndrome in chronic WAD**\   Capistrant 1976\                                                                                                    -86%                                                                                                              5 Cohort studies           Very low: due to risk of bias, directness, precision, reporting bias
  **N = 318**                                                                                                                                                                                                                                                                                                     

  Capistrant 1986                                -36%                                                                                                                                                                                                                                                             

  Magnusson 1994                                 -31.6%                                                                                                                                                                                                                                                           

  Kai 2001                                       74%                                                                                                                                                                                                                                                              

  Alexandre 2005                                 -Positive secondary to BPI                                                                                                                                                                                                                                       

  **Brachial Plexus in all WAD**\                Ide 2001                                                                                                            BPI 38%                                                                                                           4 case control,3 cohort    Very low: due to risk or bias, directness and precision
  **(n = 620)**                                                                                                                                                                                                                                                                                                   

  Sterling 2002 (WADII/III)\                     -WAD -26.21 (95%CI -28.05, -24.37), VAS 4.93 (4.6, 5.3)\                                                                                                                                                                                                         
  Chronic                                        -Control -12.92 (95%CI -15.24, -10.6), VAS 2.62 (2.2, 3.04)                                                                                                                                                                                                      

  Sterling 2003b (WADII/III)\                    **\<1 months post injury \[mean (SD)**\                                                                                                                                                                                                                          
  Acute/sub-acute                                • Recovered group -23.95 (2.4) degrees, VAS 1.8 (04)\                                                                                                                                                                                                            
                                                 • Mild pain -33.97 (2.6) degrees, VAS 3.2 (0.5)\                                                                                                                                                                                                                 
                                                 • Moderate/severe pain -34.27 (3.4) degrees, VAS 4.1 (0.5)\                                                                                                                                                                                                      
                                                 • Control -20.67 (3.12) degrees, VAS 1.8 (04)\                                                                                                                                                                                                                   
                                                 Mild pain recovered and no different from controls at 2 months                                                                                                                                                                                                   

  Sterling 2003b (WADII/III)\                    **6 months**\                                                                                                                                                                                                                                                    
  Chronic\                                       Moderate/severe pain: continued to have higher VAS 3.4 (1.0) and reduced elbow extension (no data provided)                                                                                                                                                      

  Sterling 2004 (WADII/III)\                     **Mean (SD) degrees/VAS**\                                                                                                                                                                                                                                       
  Acute/sub-acute                                • Mild symptoms -26.7 (17.7), VAS 1.8 (1.7)\                                                                                                                                                                                                                     
                                                 • Moderate symptoms -31.3 (14.9), VAS 3.0 (1.8)\                                                                                                                                                                                                                 
                                                 • Severe symptoms -36.5 (11.8), VAS 4.3 (1.6)\                                                                                                                                                                                                                   
                                                 • Control -21.4 (10.8), VAS 1.7 (1.7)                                                                                                                                                                                                                            

  Sterling 2009 (WADI-III)\                      **Mean (SD)degrees**\                                                                                                                                                                                                                                            
  Acute                                          • S-LANSS \>12--56.5 (28)\                                                                                                                                                                                                                                       
                                                 • S-LANSS \<12--35.3 (19)                                                                                                                                                                                                                                        

  Chien 2009 (WADII)                             WAD -22.3 (27.4) degrees VAS 2.4 (2.3)\                                                                                                                                                                                                                          
                                                 Control -11 (5.9) VAS 0.7 (1.1)                                                                                                                                                                                                                                  

  Ferrari, 2010 (WADI/II                         **3 months:**\                                                                                                                                                                                                                                                   
                                                 • VAS: mean (SD)2.2 (1.2)\                                                                                                                                                                                                                                       
                                                 • Elbow extension: 41.5 (23) degrees                                                                                                                                                                                                                             

  **Brachial Plexus In acute/sub-acute WAD**\    Ide 2001                                                                                                            BPI 38%                                                                                                           2 case control,4 cohort    Very low: due to risk or bias, directness, precision
  (n = 419)                                                                                                                                                                                                                                                                                                       

  Sterling 2003b (WADII/III)                     **\<1 months post injury \[mean (SD)**\                                                                                                                                                                                                                          
                                                 • Recovered group (NDI\<8) -23.95 (2.4) degrees, VAS 1.8 (04)\                                                                                                                                                                                                   
                                                 • Mild pain (NDI 10--28) -33.97 (2.6) degrees, VAS 3.2 (0.5)\                                                                                                                                                                                                    
                                                 • Moderate/severe (NDI \>30) -34.27 (3.4) degrees, VAS 4.1 (0.5)\                                                                                                                                                                                                
                                                 • Control -20.67 (3.12) degrees, VAS 1.8 (04)                                                                                                                                                                                                                    

  Sterling 2004 (WADII/III)                      **Mean (SD)degrees/VAS** (pain & disability)\                                                                                                                                                                                                                    
                                                 • Mild (NDI 15.6) -26.7 (17.7), VAS 1.8 (1.7)\                                                                                                                                                                                                                   
                                                 • Moderate (NDI 39.5) -31.3 (14.9), VAS 3.0 (1.8)\                                                                                                                                                                                                               
                                                 • Severe (NDI 69.5)-36.5 (11.8), VAS 4.3 (1.6)\                                                                                                                                                                                                                  
                                                 • Control -21.4 (10.8), VAS 1.7 (1.7)                                                                                                                                                                                                                            

  Sterling 2009 (WADI-III)                       Mean (SD)degrees\                                                                                                                                                                                                                                                
                                                 • S-LANSS \>12--56.5 (28)\                                                                                                                                                                                                                                       
                                                 • S-LANSS \<12--35.3 (19)                                                                                                                                                                                                                                        

  Ferrari, 2010 (WADI/II)                        **3 months:**\                                                                                                                                                                                                                                                   
                                                 • VAS: mean (SD)2.2 (1.2)\                                                                                                                                                                                                                                       
                                                 • Elbow extension: 41.5 (23) degrees                                                                                                                                                                                                                             

  **Brachial Plexus In chronic WAD**\            Sterling 2002 (WADII/III)\                                                                                          -WAD -26.21 (95%CI -28.05, -24.37), VAS 4.93 (4.6, 5.3)\                                                          4 case control, 2 cohort   Very low: due to risk or bias, directness, precision
  (n = 432)                                                                                                                                                          -Control -12.92 (95%CI -15.24, -10.6), VAS 2.62 (2.2, 3.04)\                                                                                 
                                                                                                                                                                     -Mild (NDI 10--28): recovered and no different from controls at 2 months                                                                     

  Sterling 2003b (WADII/III)                     **6 months**\                                                                                                                                                                                                                                                    
                                                 Moderate/severe (NDI \>30): continued to have higher VAS 3.4 (1.0) and reduced elbow extension (no data provided)                                                                                                                                                

  Sterling 2004 (WADII/III)                      **Mean (SD)degrees/VAS** (pain & disability)\                                                                                                                                                                                                                    
                                                 • Mild (NDI 15.6) -26.7 (17.7), VAS 1.8 (1.7)\                                                                                                                                                                                                                   
                                                 • Moderate (NDI 39.5) -31.3 (14.9), VAS 3.0 (1.8)\                                                                                                                                                                                                               
                                                 • Severe (NDI 69.5)-36.5 (11.8), VAS 4.3 (1.6)\                                                                                                                                                                                                                  
                                                 • Control -21.4 (10.8), VAS 1.7 (1.7)                                                                                                                                                                                                                            

  Chien 2009 (WADII)                             WAD -22.3 (27.4) degrees VAS 2.4 (2.3)\                                                                                                                                                                                                                          
                                                 Control -11 (5.9) VAS 0.7 (1.1)                                                                                                                                                                                                                                  

  Sterling 2009 (WADI-III)                       **Mean (SD) degrees**\                                                                                                                                                                                                                                           
                                                 • S-LANSS \>12--56.5 (28)\                                                                                                                                                                                                                                       
                                                 • S-LANSS \<12--35.3 (19)                                                                                                                                                                                                                                        

  **Brachial Plexus In WADII/III**\              Sterling 2002 (WADII/III)\                                                                                          WAD -26.21 (95%CI -28.05, -24.37), VAS 4.93 (4.6, 5.3)\                                                           4 case control             Very low: due to risk or bias, directness
  (n = 416)                                      Chronic                                                                                                             Control -12.92 (95%CI -15.24, -10.6), VAS 2.62 (2.2, 3.04)                                                                                   

  Sterling 2003b (WADII/III) acute/sub-acute     **\<1 months post injury \[ROM mean (SD)** (classified per pain & disability)\                                                                                                                                                                                   
                                                 • Recovered group (NDI\<8) -23.95 (2.4) degrees, VAS 1.8 (04)\                                                                                                                                                                                                   
                                                 • Mild pain (NDI 10--28) -33.97 (2.6) degrees, VAS 3.2 (0.5)\                                                                                                                                                                                                    
                                                 • Moderate/severe (NDI \>30) -34.27 (3.4) degrees, VAS 4.1 (0.5)\                                                                                                                                                                                                
                                                 • Control -20.67 (3.12) degrees, VAS 1.8 (04)\                                                                                                                                                                                                                   
                                                 Mild (NDI 10--28):recovered and no different from controls at 2 months                                                                                                                                                                                           

  Sterling 2003b (WADII/III) Chronic             **6 months**\                                                                                                                                                                                                                                                    
                                                 Moderate/severe (NDI\>30): continued to have higher VAS 3.4 (1.0) and reduced elbow extension (no data provided)                                                                                                                                                 

  Sterling 2004 (WADII/III)\                     **Mean (SD)degrees/VAS** (pain & disability)\                                                                                                                                                                                                                    
  Acute/sub-acute                                • Mild (NDI 15.6) -26.7 (17.7), VAS 1.8 (1.7)\                                                                                                                                                                                                                   
                                                 • Moderate (NDI 39.5) -31.3 (14.9), VAS 3.0 (1.8)\                                                                                                                                                                                                               
                                                 • Severe (NDI 69.5)-36.5 (11.8), VAS 4.3 (1.6)\                                                                                                                                                                                                                  
                                                 • Control -21.4 (10.8), VAS 1.7 (1.7)                                                                                                                                                                                                                            

  Chien 2009 (WADII)                             WAD -22.3 (27.4) degrees, VAS 2.4 (2.3)\                                                                                                                                                                                                                         
                                                 Control -11 (5.9), VAS 0.7 (1.1)                                                                                                                                                                                                                                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BPI: brachial plexus irritation, BPPT: brachial plexus provocation test, NDI: Neck Disability Index, VAS: visual analogue scale, ROM: range of movement, S-LLANS: short version Leeds Assessment of Neuropathic Symptoms and Signs

10.1371/journal.pone.0194235.t008

###### Muscle dysfunction (muscle activation, pain and trigger points).

![](pone.0194235.t008){#pone.0194235.t008g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                                                                         Studies                                                               Findings\                                                           Grade                                 Overall GRADE
                                                                                                                                                        Percentage (SD) change in activation (EMG) unless stated                                                  
  ------------------------------------------------------------------------------- --------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------- ---------------------------------------------------------------------------
  **Muscle activation: all muscles-** (n = 220)                                   Klein 2001                                                            -no change                                                          4 case control, 1 single case study   Very low---due to risk or bias, precision, consistency, directness

  Sterling 2003a                                                                  SCM (CCFT)\                                                                                                                                                                     
                                                                                  • Recovered 29(4),\                                                                                                                                                             
                                                                                  • Mild 27(3),\                                                                                                                                                                  
                                                                                  • Moderate/severe 40(4),\                                                                                                                                                       
                                                                                  • Control 16(3)                                                                                                                                                                 

  Sterling 2004 (acute)                                                           SCM (CCFT)\                                                                                                                                                                     
                                                                                  • Control 13(3),\                                                                                                                                                               
                                                                                  • Mild 32 (3),\                                                                                                                                                                 
                                                                                  • Mod 29(4);\                                                                                                                                                                   
                                                                                  • Severe 47(4)                                                                                                                                                                  

  Omar 2007 (chronic WADIII)                                                      -Weak mid/lower trapezius                                                                                                                                                       

  Helgadottir 2011b                                                               -serratus anterior delayed onset, mid/ low trapezius unchanged                                                                                                                  

  **Muscle activation: all muscle- Acute/sub-acute**(n = 146)                     Sterling 2003a                                                        SCM (CCFT)\                                                         2 case control                        Very low--due to risk of bias
                                                                                                                                                        • Recovered 29 (4)\                                                                                       
                                                                                                                                                        • Mild 27 (3)\                                                                                            
                                                                                                                                                        • Moderate/severe 40 (4)\                                                                                 
                                                                                                                                                        Control 16 (3)                                                                                            

  Sterling 2004                                                                   \- SCM (CCFT)\                                                                                                                                                                  
                                                                                  Control 13 (3), Mild 32 (3), Mod 29 (4), Severe 47 (4)                                                                                                                          

  **Muscle activation: all muscles- Chronic WAD**(n = 73)                         Klein 2001                                                            -no change                                                          2 case control, 1 single case study   Very low---due to risk or bias, precision, consistency and directness

  Omar 2007                                                                       -Weak mid/lower trapezius                                                                                                                                                       

  Helgadottir 2011b                                                               -serratus anterior delayed onset, mid and lower trapezius unchanged                                                                                                             

  **Muscle activation: SCM (All stages)** (n = 192)                               Klein 2001                                                            -no change                                                          3 case control                        Very low---due to risk or bias, precision, consistency and directness

  Sterling 2003a                                                                  SCM (CCFT)\                                                                                                                                                                     
                                                                                  • Recovered 29 (4),\                                                                                                                                                            
                                                                                  • Mild 27 (3),\                                                                                                                                                                 
                                                                                  • Moderate/severe 40 (4)                                                                                                                                                        

  Sterling 2004                                                                   SCM (CCFT)\                                                                                                                                                                     
                                                                                  • Control 13 (3),\                                                                                                                                                              
                                                                                  • Mild 32 (3),\                                                                                                                                                                 
                                                                                  • Mod 29 (4),\                                                                                                                                                                  
                                                                                  • Severe 47 (4)                                                                                                                                                                 

  **Muscle activation: SCM- Sub-acute WAD II/III** (n = 66)                       Sterling 2003a\                                                       SCM (CCFT)\                                                         1 case control                        Very low--due to risk of bias
                                                                                                                                                        • Recovered 29 (4)\                                                                                       
                                                                                                                                                        • Mild 27 (3)\                                                                                            
                                                                                                                                                        • Moderate/severe 40 (4)\                                                                                 
                                                                                                                                                        • Control 16 (3)                                                                                          

  Muscle activation: SCM-Chronic WAD II/III (n = 126)                             Klein 2001                                                            -no change\                                                         2 case control                        Very low---due to risk or bias, precision, consistency

  Sterling 2004                                                                   SCM (CCFT)\                                                                                                                                                                     
                                                                                  • Control 13 (3)\                                                                                                                                                               
                                                                                  • Mild 32 (3)\                                                                                                                                                                  
                                                                                  • Mod 29 (4)\                                                                                                                                                                   
                                                                                  • Severe 47 (4)                                                                                                                                                                 

  **Myofascial pain and trigger points: all muscles -Sub-acute WADII** (n = 20)   Fernandez-de-las-Perez 2012\                                          **Number of TPs**\                                                  1 case control                        Very low---due to risk or bias
                                                                                                                                                        • **WAD Scalene:** Active R6, L4; Latent R9, L10; No R5, L6\                                              
                                                                                                                                                        • **Control Scalene:** Active R0, L0; Latent R2, L4; No R18, L16\                                         
                                                                                                                                                        • **WAD SCM:** Active R1, L6; Latent R12, L9; No R7, L5\                                                  
                                                                                                                                                        • **Control SCM:** Active R0, L0; Latent R4, L5; No R6, L15                                               

  **Myofascial pain and trigger points: all muscles-Chronic WAD**(n = 121)        Bismil 2005 (WADII)                                                   **Prevalence:** 48%                                                 2 case control, 1 cohort              Very low---due to risk or bias, reporting bias, directness

  Ettlin 2008\                                                                    **Prevalence:**\                                                                                                                                                                
                                                                                  • **WAD:** Scaleneus medius 63.8%, SCM 51.1%\                                                                                                                                   
                                                                                  • **Control:** Scaleneus medius 12.5%, SCM 12.5%                                                                                                                                

  Castaldo 2014 (WADII & III)                                                     **Number of TPs (SCM)**\                                                                                                                                                        
                                                                                  • **WAD:** Active L 21, R 22; Latent L 13, R 15\                                                                                                                                
                                                                                  • **Control** (MNP): Active L 13, R 13; Latent L 6, R 9                                                                                                                         

  **Myofascial pain: Trapezius (mid/low)**\                                       Bismil 2005                                                           Prevalence: 48%                                                     1 cohort                              Very low---due to risk or bias, precision, reporting bias, directness
  **Chronic WADII** (n = 25)                                                                                                                                                                                                                                      

  **Myofascial pain and trigger points: SCM-**\                                   Ettlin 2008                                                           **Prevalence**\                                                     3 case control                        Very low---due to risk or bias, precision (?), reporting bias, directness
  **Chronic and sub-acute WAD** (n = 116)                                                                                                               • **WAD:** 51.1%\                                                                                         
                                                                                                                                                        • **Control:** 12.5%                                                                                      

  Fernandez-de-las-Perez 2012\                                                    **Number of TPs**\                                                                                                                                                              
                                                                                  • **WAD:** Active R1, L6; Latent R12, L9; No R7, L5\                                                                                                                            
                                                                                  • **Control:** Active R0, L0; Latent R4, L5; No R 6, L15                                                                                                                        

  Castaldo 2014\                                                                  **Number of TPs**\                                                                                                                                                              
                                                                                  • **WAD:** Active L 21, R 22; Latent L 13, R 15\                                                                                                                                
                                                                                  • **Control (MNP):** Active L13, R 13; Latent MTP L 6, R 9                                                                                                                      

  **Myofascial pain and trigger points: Scalene-**\                               Ettlin 2008                                                           **Prevalence**\                                                     2 case control                        Very low---due to risk or bias, precision, directness
  **Chronic WAD and sub-acute** (n = 67)                                                                                                                • WAD: 63.8%\                                                                                             
                                                                                                                                                        • Control: 12.5%                                                                                          

  Fernandez-de-las-Perez 2012                                                     **Number of TPs**\                                                                                                                                                              
                                                                                  • **WAD**: Active R 6, L4; Latent R 9, L10; No R 5, L6\                                                                                                                         
                                                                                  • **Control**: Active R0, L0; Latent R2, L4; No R 18, L16                                                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SCM: sternocleidomastoid, CCFT: craniocervical flexion test, MTP: myofascial trigger points, MNP: mechanical neck pain

### Thoracic spine pain {#sec026}

Despite the very low quality of included studies, there is evidence of thoracic spine pain in a sub-acute WAD population (n = 11,576) \[[@pone.0194235.ref011], [@pone.0194235.ref014], [@pone.0194235.ref017], [@pone.0194235.ref034], [@pone.0194235.ref039], [@pone.0194235.ref043], [@pone.0194235.ref052], [@pone.0194235.ref060]\], with prevalence ranging between 21%-66%,. Findings were inconsistent in chronic WAD, with prevalence ranging 0--94% \[[@pone.0194235.ref017], [@pone.0194235.ref050]\]. Study quality, differing time points post injury, differing measurement approaches and higher degrees of WAD severity could partly account for the inconsistency. For example, chronic WAD, studies with less severe presentations (minor or WADII) \[[@pone.0194235.ref032], [@pone.0194235.ref050]\] demonstrated lower prevalence rates (0--15.3%) compared to studies investigating WADII/III where prevalence was 54% \[[@pone.0194235.ref058]\]. Just one study reporting thoracic pain specifically associated with central sensitisation (allodynia) where pain prevalence was 71% in individuals with CWADI/II \[[@pone.0194235.ref033]\].

### Chest pain {#sec027}

Prevalence of chest pain in acute/sub-acute was reported to range 0.0--19% \[[@pone.0194235.ref011], [@pone.0194235.ref014], [@pone.0194235.ref017], [@pone.0194235.ref052]\], although when considered as part of a widespread pain presentation ranged 9--19% \[[@pone.0194235.ref011], [@pone.0194235.ref014]\]. In one study where they only considered individuals with numerical rating scale (NRS 0--10) 4+ chest pain prevalence was lower at 8% \[[@pone.0194235.ref052]\]. In CWAD prevalence rates for chest pain ranged 6--22% \[[@pone.0194235.ref017], [@pone.0194235.ref053]\] although this reflects a, broad timescale with one study reporting results 6 month post injury \[[@pone.0194235.ref017]\] to one exploring prevalence at any time point following injury \[[@pone.0194235.ref053]\]. Drawing definitive conclusions on prevalence of chest pain is difficult given variation in approaches used to record pain (pain drawings, VAS, *etc*.), time points post injury, sample heterogeneity and the overall methodological low quality of research. This may also be a related to the focus of this review, being to those with mild to moderate presentations of WAD where studies including WADIV or fractures were excluded.

### Thoracic posture {#sec028}

Evidence of thoracic postural dysfunction is inconclusive given conflicting findings from a small number of studies of low methodological quality evidence where postural assessment was not a primary focus \[[@pone.0194235.ref044], [@pone.0194235.ref061]\]. Future studies should consider the use of a gold standard measure for postural evaluation \[[@pone.0194235.ref063]\].

### Thoracic mobility and chest mobility {#sec029}

There is a notable gap in the evidence exploring thoracic and chest mobility in WAD, with just two studies (n = 54) of very low quality suggesting a trend for reduced chest mobility (p\>0.05) and flexion hypomobility at the cervico-thoracic junction in women. In terms of thoracic mobility, evidence from one study (n = 7) \[[@pone.0194235.ref061]\] suggests a slight increase in thoracic flexion-extension, although with such a small sample and lack of inclusion of a valid approach to quantify thoracic mobility, meaningful conclusions cannot drawn.

### Thoracic outlet syndrome in CWAD {#sec030}

Five studies found, a prevalence of 31--74+% \[[@pone.0194235.ref031], [@pone.0194235.ref035], [@pone.0194235.ref036], [@pone.0194235.ref047], [@pone.0194235.ref051]\] of thoracic outlet syndrome in CWAD. Although this suggests a relatively high prevalence, the methodological quality of included studies was generally poor (\<4/9), resulting in a very low rating of quality according to GRADE.

### Brachial plexus {#sec031}

**Acute/sub-acute WAD**

Notwithstanding that evidence is drawn principally from one research group, there is evidence of thoracic dysfunction in relation to the brachial plexus provocation test (BPPT) in WADI-III. From the research by Sterling et al \[[@pone.0194235.ref012], [@pone.0194235.ref057], [@pone.0194235.ref059]\], there is evidence of a negative association between self-report symptom severity (VAS) and range of elbow extension during the BPPT in chronic WAD. Moreover, the extent of this dysfunction is in turn related to the degree of pain and disability, with those participants presenting with higher levels of self-reported pain and disability (NDI) having greater levels of dysfunction during BPPT.

**Chronic WAD**

For participants with CWADII and/or III, evidence indicates dysfunction detected during the BPPT, with pain levels and restriction in elbow extension almost double those found in asymptomatic controls \[[@pone.0194235.ref038], [@pone.0194235.ref055]\]. Furthermore, those with higher levels of self-reported pain and disability (NDI\>30) continued to have evidence of dysfunction 6 months after the injury which was not seen in the mild group who were no different to the recovered group at 2 months \[[@pone.0194235.ref057]\]. Although quality of individual studies varied (4-6/9), the overall body of evidence for dysfunction of the brachial plexus remains very low overall, primarily due to risk of bias of the included studies.

### Muscle activation {#sec032}

There are limited and very variable findings of thoracic muscle dysfunction (activation) in WAD with studies investigating a relatively small number of muscles: sternocleidomastoid \[[@pone.0194235.ref012], [@pone.0194235.ref049], [@pone.0194235.ref056]\]; serratus anterior \[[@pone.0194235.ref045]\]; middle and lower fibres of trapezius \[[@pone.0194235.ref045], [@pone.0194235.ref054]\]. Although it is difficult to derive meaningful conclusions with respect to serratus anterior and trapezius, there is evidence supporting changes in sternocleidomastoid muscle activation with heightened levels of activation during a task of cranio-cervical flexion; this increase in sternocleidomastoid activity however, was not seen during neck rotation \[[@pone.0194235.ref049]\]. There appears to be a positive relationship between sternocleidomastoid activation and higher levels of pain severity, with participants with CWADII/III and moderate to severe levels of disability demonstrating increased levels of sternocleidomastoid activation of between 27--47% \[[@pone.0194235.ref012], [@pone.0194235.ref056]\]. Individuals with mild, moderate/severe presentations all share comparative levels of sternocleidomastoid activation in the acute \[[@pone.0194235.ref056]\] and chronic phases \[[@pone.0194235.ref012]\].

### Myofascial pain and trigger points {#sec033}

Myofascial trigger points are highly prevalent in WAD with estimates ranging between 48--64% \[[@pone.0194235.ref016], [@pone.0194235.ref037], [@pone.0194235.ref040]\]. Muscles that have been investigated include the middle/lower trapezius \[[@pone.0194235.ref016]\], scaleneus medius \[[@pone.0194235.ref040], [@pone.0194235.ref041]\] and sternocleidomastoid \[[@pone.0194235.ref037], [@pone.0194235.ref040], [@pone.0194235.ref041]\], all with similar prevalence levels. Findings suggest that latent trigger points are more prevalent in sub-acute WADII \[[@pone.0194235.ref041]\] whereas in chronic WAD there is a higher prevalence of active trigger points \[[@pone.0194235.ref037]\]. It should however be noted that the sample of chronic WAD comprised both WADII and III, so perhaps severity could partly explain the differences seen. Likewise, age may account for some of the differences given the sub-acute sample was 28.7 years \[[@pone.0194235.ref041]\] compared 41.6 years in the chronic WAD group \[[@pone.0194235.ref037]\].

Discussion {#sec034}
==========

Summary of evidence {#sec035}
-------------------

This is the first methodologically rigorous systematic review investigating thoracic dysfunction in whiplash associated disorders. From a comprehensive search, 38 studies were included and evaluated as part of the review. Many studies were at risk of bias, primarily due to poor reporting with most studies published prior to the introduction of the STROBE reporting guidelines for observational studies. Notwithstanding the low quality of the evidence, there is unequivocal evidence of thoracic dysfunction in WAD.

### Pain {#sec036}

Although there is a high prevalence of acute and chronic pain experienced in the thoracic spine region following injury, distinguishing the interplay of pain mechanisms is however challenging. Whilst we know peripheral and central sensitisation begin immediately following injury \[[@pone.0194235.ref064]\], it is plausible that damage to thoracic musculoskeletal tissues contributes to the relatively high prevalence of pain reported in the acute/sub-acute stages from peripheral nociceptor stimuli \[[@pone.0194235.ref011], [@pone.0194235.ref014], [@pone.0194235.ref017], [@pone.0194235.ref043], [@pone.0194235.ref052]\]. Relatively few studies in this review reported perceived pain levels e.g. VAS, making it difficult to consider an association between injury severity and tissue damage. Although reviewed in detail by Van Oosterwijck et al, \[[@pone.0194235.ref064]\] the current review found just one study reporting thoracic pain specifically associated with central sensitisation, with allodynia reported in 71% of individuals with CWADI/II \[[@pone.0194235.ref033]\], arguably contributing to the lack of consistency with findings for chronic WAD where differing pain mechanisms may co-exist. Likewise distinguishing local from referred pain is challenging where injury in the cervical spine may refer pain caudally to the upper and mid thoracic region \[[@pone.0194235.ref065]\]. Unlike the thoracic spine, reported chest pain prevalence was relatively low, perhaps more closely associated with severe injuries, including fractures, which were excluded from this review. Future studies should, in addition to using the QTF Classification, include self-reported pain severity for each anatomical region.

### Thoracic posture and mobility {#sec037}

With limited very low quality evidence and relative to the cervical spine, there is a paucity of research investigating thoracic posture and mobility in WAD \[[@pone.0194235.ref044], [@pone.0194235.ref045], [@pone.0194235.ref048], [@pone.0194235.ref061]\]. This may be explained with priority being given to areas with most severe pain, with the cervical spine and associated tissues being most vulnerable to stress and damage compared to the relatively stable and stiff thoracic spine \[[@pone.0194235.ref021]\], arguably enhanced with the mandatory use of seatbelts offering additional stability. However, considering the effect of a forceful injury on posterior structures, and neck stiffness being a hallmark of chronic WAD further research is required, specifically to investigate thoracic posture, mobility and muscle stiffness in WAD, all of which may offer new directions for research into management of WAD.

### Thoracic outlet syndrome {#sec038}

Although this review suggests a relatively high prevalence of thoracic outlet syndrome, the quality of evidence is very low and derived from relatively older studies, including two studies from the same group of authors \[[@pone.0194235.ref035], [@pone.0194235.ref036]\]. Whilst the mechanism of injury and resultant strain on the scalene triangle in WAD would, in theory, place the thoracic outlet at risk of injury, this does needs to be investigated further. Likewise as a 'syndrome', this does not provide primary evidence of a primary structural dysfunction; it merely provides evidence of a dysfunction which, in turn, could be neurogenic, myogenic, vasculogenic in nature. Perhaps, in the absence of evidence of thoracic outlet syndrome in acute WAD, this condition is secondary to the consequences of whiplash, altered posture, changes in muscle behaviour *etc*. \[[@pone.0194235.ref066]\]. Future studies should use robust observational study designs and include valid assessment techniques to diagnose thoracic outlet syndrome.

### Brachial plexus {#sec039}

There is considerable evidence of brachial plexus dysfunction in both acute/sub-acute and chronic WAD from research investigating the brachial plexus provocation test. Although coming from a relatively small group of researchers, the evidence supports further investigation. Future research could usefully consider the relationship of brachial plexus dysfunction to other musculoskeletal changes in the cervical and thoracic spine following a whiplash injury, but also approaches to managing this; a notable gap within the whiplash management evidence \[[@pone.0194235.ref009], [@pone.0194235.ref010], [@pone.0194235.ref066]\]. Although inclusion of the brachial plexus in this review may at first appear tenuous, with contributions from the level of T1 and its relationship to the thoracic outlet, its inclusion provides good evidence to further explore this anatomically and functionally challenging cervico-thoracic-supraclavicular region; a transitional zone between the stable/stiff thoracic spine and relatively mobile cervical spine.

### Muscle activation {#sec040}

There is unequivocal evidence of altered function of muscles following whiplash injury \[[@pone.0194235.ref066]\], however this evidence is largely limited to cervical muscles, with this review identifying just three muscles with insertions to the thoracic region, sternocleidomastoid \[[@pone.0194235.ref012], [@pone.0194235.ref049], [@pone.0194235.ref056]\]; serratus anterior \[[@pone.0194235.ref045]\]; middle and lower fibres of trapezius \[[@pone.0194235.ref045], [@pone.0194235.ref054]\]. Although it is difficult to derive meaningful conclusions with so few muscles investigated and the quality of the evidence, the observed positive relationship between sternocleidomastoid activation and pain severity, and evidence across all stages post injury \[[@pone.0194235.ref012], [@pone.0194235.ref049], [@pone.0194235.ref056]\] supports the need for further research into altered activation of cervico-thoracic and thoracic muscles, ideally involving functional spinal movements; something that is now feasible with advances in technology, including high density EMG.

### Myofascial pain and trigger points {#sec041}

This review has identified that myofascial trigger points are highly prevalent in WAD \[[@pone.0194235.ref016], [@pone.0194235.ref037], [@pone.0194235.ref040]\], although again from very low quality evidence and limited to a small number of muscles; middle/lower trapezius \[[@pone.0194235.ref016]\], scaleneus medius \[[@pone.0194235.ref040], [@pone.0194235.ref041]\] and sternocleidomastoid \[[@pone.0194235.ref037], [@pone.0194235.ref040], [@pone.0194235.ref041]\]. Nonetheless all muscles have similar prevalence levels of trigger points, with a higher prevalence of latent trigger points in sub-acute WAD \[[@pone.0194235.ref041]\] and active trigger points in chronic WAD \[[@pone.0194235.ref037]\]. With evidence of trigger points across all muscles and across the stages and severity of presentations, research is now required to explore other muscles in the thoracic region and better understand the development of pain, and persistent pain seen in chronic WAD, perhaps with longitudinal studies. Notwithstanding the quality, evidence was found of myofascial-entheseal dysfunction \[[@pone.0194235.ref016]\], a relatively new clinical entity and arguably similar to insertional tendinopathies. With rapid advances in our understanding of injury induced tendinopathies in the lower limb, this does offer new insights to possible muscle pathologies which may contribute to persistent pain and disability seen in WAD.

This review provides unequivocal evidence of thoracic dysfunction in WAD, albeit from evidence of low/very low quality. The findings do support a more extensive clinical evaluation of patients following a whiplash injury and the need for more methodologically robust observational studies to further characterise thoracic dysfunction in WAD across stages of the condition and levels of severity. Knowledge and understanding of thoracic dysfunction, where anatomical and biomechanical relationships with the cervical spine exist, offers novel directions for research into management of this disabling condition.

Research into WAD management has been, and continues to be primarily focused on managing cervical spine dysfunction, with interventions such as manual therapy, exercise *etc*. targeting the cervical spine \[[@pone.0194235.ref066]\], and targeting the psychological impact of a whiplash injury \[[@pone.0194235.ref066]\]. With inconclusive evidence of the therapeutic value of the above \[[@pone.0194235.ref067]\] it is perhaps time to consider new directions for research.

Whilst exercise as part of multimodal packages of care is recommended in the management of acute and chronic WAD \[[@pone.0194235.ref066], [@pone.0194235.ref068]\], the range of approaches available are considerable e.g. graded functional exercise, postural exercises, and strengthening and motor control exercises *etc*.\[[@pone.0194235.ref066]\]. The authors are not however aware of any recommendations or research specifically supporting the inclusion of thoracic spine exercises, although these could reasonably be incorporated within functional exercise programmes. With at best short term modest improvements in current exercise interventions \[[@pone.0194235.ref009], [@pone.0194235.ref010]\] and some evidence of some therapeutic value of thoracic spine manipulation in WAD \[[@pone.0194235.ref069]\] further research to investigate interventions targeting the thoracic spine and related dysfunction is justified.

It has not until recent years that the thoracic spine, coined the 'Cinderella' of the spine \[[@pone.0194235.ref021]\], has started to receive more research interest. This has been attributed partly to the relatively lower prevalence of symptoms than the cervical and lumbar spine more generally, but also due to the lack of affordable, non-invasive and valid measurement tools to evaluate motion in this anatomically complex and relatively stiff spinal region \[[@pone.0194235.ref021]\]. With the development of new measurement approaches for thoracic posture and mobility \[[@pone.0194235.ref063], [@pone.0194235.ref070], [@pone.0194235.ref071]\] we now have tools to support research of thoracic posture and mobility in the thoracic spine region in painful neck disorders.

Strengths and limitations of this review {#sec042}
----------------------------------------

This review is rigorous and original, with a design and focus on the thoracic spine region using a pre-defined rigorous and published protocol with subject and methodological experts contributing to the evaluation. The key limitation of the review is lack of high quality evidence and compounding this was that few authors responded to requests for additional information or data.

Conclusions {#sec043}
===========

This first and rigorous systematic review found considerable evidence of thoracic pain and dysfunction in patients at all stages following whiplash injury. Notwithstanding the low/very low level of evidence, our findings do support a more extensive clinical evaluation of patients presenting with WAD. Key findings include 1) a high prevalence of thoracic spine pain, with the highest levels of pain immediately following injury and in more severe presentations 2) evidence of muscle dysfunction (delayed onset or heightened levels of activity) in a limited number of muscles 3) evidence of thoracic outlet syndrome and brachial plexus involvement 4) inconclusive/limited evidence of postural changes and effect on thoracic spinal mobility. Additional high quality research is required to further characterise dysfunction across other structures in the thoracic region, including but not limited to the thoracic spine (mobility and posture) and thoracic muscles (stiffness, activation patterns). In turn this may inform the design of clinical trials targeting such dysfunction.
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